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ABSTRACT 
Polyfluorochemicals (PFCs) are industrial compounds that tend to bioaccumulate in humans and 
may be associated with impaired renal and liver function. Differences in background exposure to 
PFCs in the general population exist worldwide, which suggest that populations with lower 
exposure concentrations, such as foreign-born U.S. residents, may have lower risk for adverse 
health effects associated with PFCs. Using data from the 2007-2012 waves of US National 
Health and Nutritional Examination Survey (NHANES) this study investigated differences in 
serum concentrations of perfluorooctanoic acid, (PFOA), perfluoroctane sulfonic acid (PFOS), 
perfluorohexane sufonic acid (PFHxS) and perfluorononanoic acid (PFNA) among native-born 
and foreign-born U.S. residents; and examined the association between these chemicals and 
estimated glomerular filtration rate (eGFR), Alanine aminotransferase (ALT), γ-
glutamylytransferase (GGT) and total bilirubin among foreign-born U.S. residents, and on 
stratifying by length of residence (LOR). Additionally, the association between joint exposures 
to multiple PFCs and renal and liver function was examined. 
The results showed that least square geometric mean concentrations of PFOA and PFHxS were 
higher, and least square mean of eGFR was lower among native-born when compared to foreign-
born residents. As LOR increased, mean and median concentrations of PFOS and PFHxS 
significantly increased, and mean eGFR decreased.  LogPFOA, logPFHxS, and logPFNA 
concentrations were significantly associated with increased odds of having low eGFR. The 
associations remained significant among individuals who had been resident for 10-19 years, and 
20+ years.  Differences in the mean and median concentrations of ALT, GGT, and Total 
bilirubin between foreign-born and native-born residents, and by LOR were inconclusive. 
Similarly, significant associations between the selected PFCs and liver function indicators were 
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not conclusive. Increasing quartiles of a combined PFOS/PFHxS exposure variable was 
associated with increased odds of low eGFR, and elevated total bilirubin.   
Findings from this study suggest that differences in exposure to PFCs exist among native-and 
foreign-born U.S. residents. Also, increasing serum concentrations of some PFCs with increasing 
LOR may be associated with increased risk for decreased renal function. Longitudinal studies 
among new U.S. residents can help determine whether exposure to low background 
concentrations of the selected PFCs may be associated with any negative health effects over 
time. There are currently no studies on the combined effect of exposure to multiple PFCs.  The 
findings of this study can serve as the basis for future studies on the association between 
combined exposures and adverse health outcomes. 
  
PFCS AND RENAL AND LIVER FUNCTION AMONG FOREIGN-BORN 
v 
 
ACKNOWLEDGEMENTS 
 
 
 
First, I am grateful to God for granting me the strength and mercy to get this far in my education.  
 
I wish to express my sincerest gratitude to my dissertation committee members, Dr. Christina 
Fuller, and Dr. Dora Il’yasova for providing their professional expertise, feedback, and support 
to make my research possible. I would especially like to thank my committee chairperson, Dr. 
Ike Okosun for his support and mentorship throughout my studies at the School of Public Health, 
and during the dissertation process. 
 
Additionally, I would like to extend my thanks to my professors within the School, and other 
institutions within the Georgia State University, for imparting their knowledge to me. And the 
fellow students, thank you for the friendships and support that will last a lifetime. 
   
Most importantly, I would also like to thank my parents, Comfort Nyarkoah and Jonnah 
Morrison and my siblings for their continued love and support.  
PFCS AND RENAL AND LIVER FUNCTION AMONG FOREIGN-BORN 
vi 
 
TABLE OF CONTENTS 
CHAPTER I: INTRODUCTION AND STATEMENT OF PURPOSE  .......................................1 
Background .....................................................................................................................................1   
Study Purpose  ................................................................................................................................6 
Research Questions .........................................................................................................................6 
CHAPTER II: LITERATURE REVIEW .......................................................................................8   
Toxicology of PFCs ........................................................................................................................8 
Perfluorooctanoic acid (PFOA) ....................................................................................................10 
Perfluorooctane sulfonic acid (PFOS) ..........................................................................................18 
Perfluorohexane sulfonic acid (PFHxS) .......................................................................................22 
Perfluorononanoic acid (PFNA) ...................................................................................................27 
Current PFC Health Advisories ....................................................................................................28 
Background concentrations of PFCs in the General Population in various countries ..................29 
Geographical Location as a Health Determinant ..........................................................................36 
Length of Residence as a Health Determinant  .............................................................................38 
Environmental Chemical Mixtures  ..............................................................................................39 
The Foreign-born U.S. Population ................................................................................................44 
Summary .......................................................................................................................................45 
CHAPTER III: METHODS ..........................................................................................................47 
Data Source ...................................................................................................................................47  
Independent Variables ..................................................................................................................47   
Outcome Variables .......................................................................................................................48 
Statistical Analysis ........................................................................................................................49 
CHAPTER IV: RESULTS ............................................................................................................52 
Demographic Characteristics of Study Sample ............................................................................52   
PFCS AND RENAL AND LIVER FUNCTION AMONG FOREIGN-BORN 
vii 
 
Associations between PFCs and Renal Function ..........................................................................52 
Association between PFCs and Liver Function Indicators ...........................................................54  
Association between Combined Exposure to PFCs and Renal and Liver Function ……………56    
 CHAPTER V: DISCUSSION, CONCLUSIONS AND RECOMMENDATIONS ……………58 
Discussion .....................................................................................................................................58   
Associations between PFCs and Renal Function ……………………………………………….58   
Association between PFCs and Liver Function Indicators ……………………………………...61 
Association between Combined Exposure to PFCs and Renal and Liver Function …………….63 
Limitations ....................................................................................................................................63   
Conclusions and Recommendations .............................................................................................65   
Tables ……………………………………………………………………………………………68  
REFERENCES .............................................................................................................................83 
APPENDICES ............................................................................................................................122   
 
  
PFCS AND RENAL AND LIVER FUNCTION AMONG FOREIGN-BORN 
viii 
 
LIST OF TABLES 
Table 1: Demographic characteristics of study population 
Table 2: Blood concentration of PFOA, PFOS, PFHxS and PFNA in overall sample and stratified 
by place of birth, and length of residence   
Table 3: Correlation matrix of selected PFCs 
Table 4: Least square geometric mean (LSGM) concentrations of PFOA, PFNA, and PFHxS by 
country of birth and length of residence 
Table 5. Mean and least square mean (LSM) eGFR by place of birth, and length of residence 
Table 6.  Odds ratios (OR) of having low eGFR for a unit increase in PFOA, PFOS, PFHxS, and 
PFNA concentrations   
Table 7. Mean and least square mean (LSM) of alanine aminotransferase (ALT) (IU/L) by place 
of birth, and length of residence 
Table 8. Mean and least square mean (LSM) of gamma glutamyl transferase (GGT) (IU/L) by 
place of birth, and length of residence 
Table 9. Mean and least square mean (LSM) of total bilirubin (mg/dL) by place of birth, and 
length of residence  
Table 10.  Odds ratios (OR) of having elevated ALT for a unit increase in PFOA, PFOS, PFHxS, 
and PFNA concentrations   
Table 11.  Odds ratios (OR) of having elevated GGT for a unit increase in PFOA, PFOS, PFHxS, 
and PFNA concentrations   
Table 12.  Odds ratios (OR) of having elevated total bilirubin for a unit increase in PFOA, PFOS, 
PFHxS, and PFNA concentrations   
Table 13:  Assessment of the factor loading matrix of PFC serum concentration principal 
components   
Table 14: Crude and adjusted logistic regression of PFC serum concentration principal 
components and risk of low eGFR 
Table 15: Crude and adjusted logistic regression of PFC serum concentration principal 
components and risk of elevated ALT  
 
PFCS AND RENAL AND LIVER FUNCTION AMONG FOREIGN-BORN 
ix 
 
Table 16: Crude and adjusted logistic regression of PFC serum concentration principal 
components and risk of elevated GGT 
Table 17: Crude and adjusted logistic regression of PFC serum concentration principal 
components and risk of elevated total bilirubin 
Appendix 1: International guideline health-based values for PFOA and PFOS 
 
  
PFCS AND RENAL AND LIVER FUNCTION AMONG FOREIGN-BORN 
x 
 
 
LIST OF FIGURES 
 
Figure 1:  Molecular structure of Perfluorooctanoic acid (PFOA) 
 
Figure 2:  Molecular structure of perfluorooctane sulfonic acid (PFOS) 
 
Figure 3:  Molecular structure of perfluorohexane sulfonic acid (PFHxS) 
 
Figure 4:  Molecular structure of perfluorononoic acid (PFNA) 
  
  
PFCS AND RENAL AND LIVER FUNCTION AMONG FOREIGN-BORN 
xi 
 
LIST OF ABBREVIATIONS 
 ACS  American Chemical Society 
ALT   Alanine aminotransferase   
APFO   ammonium perfluorooctanoate   
APFO   Ammonium perfluorooctanoate   
AST   Aminotransferase   
ASTSWMO  Association of State and Territorial Solid Waste Management Officials 
BMI  Body mass index  
CAR  Constitutive androstane receptor 
CDC  Centers for Disease Control and Prevention 
CI   Confidence intervals  
CKD  Chronic kidney disease 
CVD  Cardiovascular disease 
ECA  European Chemical Agency 
ECF   Electro-Chemical Fluorination 
EFSA  European Food Safety Authority 
eGFR   Estimated glomerular filtration rate  
ER-alpha Estrogen receptor   
ETS   Environmental tobacco smoke 
FEV1  Forced expiratory volume at 1s   
FTOHs  Fluorotelomer alcohols  
FVC   Forced vital capacity  
FXR   Farnesoid X receptor  
GGT  γ-glutamylytransferase 
GLM   General linear modeling 
PFCS AND RENAL AND LIVER FUNCTION AMONG FOREIGN-BORN 
xii 
 
HNF4a Hepatocyte nuclear factor 4 alpha 
IQR  Interquartile range 
LOR   Length of residence 
LSGM  Least square geometric means 
LSM   Least Square Means 
NCBI  National Center for Biotechnology Information 
NCHS  National Center for Health Statistics 
NHANES National Health and Nutrition Examination Survey 
OECD  Organization for Economic Cooperation and Development 
OR   Odds ratio 
PAPs   Polyfluoroalkyl phosphoric Acid  
PCA   Principal component analysis  
PFCs  Perfluorocarbons 
PFHxS  Perfluorohexane sulfonic acid  
PFIs   Polyfluorinated iodides   
PFNA   Perfluorononanoic acid   
PFOA  Perfluorooctanoic acid  
PFOS   Perfluoroctane sulfonic acid  
POPs  Persistent Organic Pollutants 
POSF   Perfluorooctanesulfonyl fluoride  
PPAR   Peroxisome proliferator-activated receptor  
PPARG  Peroxisome proliferator-activated receptor gamma 
PPARα Peroxisome proliferator- activated receptor-alpha 
PXR   Pregnane X receptor  
SE  Standard error 
PFCS AND RENAL AND LIVER FUNCTION AMONG FOREIGN-BORN 
xiii 
 
TCB   Total chemical burden   
TCE   Trichloroethylene 
TDI  Tolerable Daily Intake 
TSH   Thyroid stimulating hormone   
UNEP  United Nations Environment Program 
USDHHS United States Department of Health and Human Services 
USEPA United States Environmental Protection Agency 
VOCs  Volatile organic compounds 
 
 
 
 
 
PFCS AND RENAL AND LIVER FUNCTION AMONG FOREIGN-BORN 
1 
 
 Chapter I: Introduction and Statement of Purpose 
Background 
Perfluorocarbons (PFCs) are organic compounds that consist of fully fluorinated carbon 
chains, between four to twelve carbons long, with either a carboxylic acid, sulfonic acid, or 
alcohol end chain group (C.  Lau, 2012).  For instance, perfluorooctanoic acid (PFOA) is an 8- 
carbon chain with a carboxylic acid end group (Figure 1); perfluoroctane sulfonic acid (PFOS) is 
an 8-carbon chain with a sulfonic acid end group (Figure 2); perfluorohexane sulfonic acid 
(PFHxS) is a 6-carbon chain with a sulfonic acid end group (Figure 3); and perfluorononanoic 
acid (PFNA) is 9-carbons long with a carboxylic acid end group (Figure 4) (De Silva & Mabury, 
2004);  The strong carbon-fluorine bonds make PFCs extremely stable and resistant to thermal 
and chemical degradation  (European Food Safety Authority (EFSA), 2008; Olsen et al., 2007; 
United States Environmental Protection Agency (USEPA), 2009). They are non-flammable, non-
volatile, non-oxidized even with strong acids or bases, stable in extremely elevated temperatures, 
and highly resistant to biodegradation (C.  Lau, 2012; USEPA, 2009). Due to these properties, 
PFCs are useful for many industrial applications, including water repellant coating for carpets, 
textiles, leather, and food packing materials; as well as cleaning agents in cosmetics and fire-
fighting foams (Fromme, Tittlemier, Völkel, Wilhelm, & Twardella, 2009; Hekster, Laane, & de 
Voogt, 2003; Organization for Economic Cooperation and Development (OECD), 2002).  
However, these properties also make them persistent compounds which are bioaccumulative and 
toxic to both humans and the environment. Hence, they are included in the Stockholm 
Convention on Persistent Organic Pollutants (POPs)  (OECD, 2002).   
Between 1970 and 2002, cumulative global production of PFC chemicals stood at nearly 
100,000 metric tons (Paul, Jones, & Sweetman, 2009). It is estimated that since production of 
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PFCs began in the 1950s, up to 45,300 metric tons of PFCSs have been released into the 
environment, of which more than 95% have been released directly into aquatic environments 
(Ahrens, Yeung, Taniyasu, Lam, & Yamashita, 2011; Paul et al., 2009). Due to the concerns 
about their toxic effects on humans and the environment, a voluntary phase-out of the production 
of PFCs, in particular PFOS, started in the year 2000 (American Chemical Society (ACS), 2010). 
By 2003, PFOS production in the United States had ceased (USEPA, 2009), with a goal of 
reducing emissions by 95% by 2010 and eliminating emissions completely by 2015 (ACS, 
2010).  However, existing stocks and products already in the United States before rules stopping 
PFOS manufacture took effect in 2002, can still be used without any restrictions (USEPA, 2009, 
2016a).  Most developed countries have followed suit, but production of PFOS-related chemicals 
has continued on a smaller extent since 2003 in other countries (Houde, De Silva, Muir, & 
Letcher, 2011; Lim, Wang, Huang, Deng, & Yu, 2011). For instance, with the phase-out of 
Perfluorooctane sulfonic acid(PFOS) manufacturing in the United States by 3M, the principal 
producer, large-scale production has continued in China (Lim et al., 2011). Annual production of 
PFOS in China increased from less than 50 tons in 2004, to 200 tons in 2006, of which nearly 
50% was designated for export (Lim et al., 2011; Liu et al., 2017). And in the U.S., limited 
quantities of PFOS can still be imported (USEPA, 2009). Due to these factors, and the 
persistence of PFCs, populations worldwide are bound to be exposed to background levels of 
these chemicals for the conceivable future.    
In recent years, PFCs have become a focus of public health concern due to their 
ubiquitous presence in the environment. Environmental contamination occurs in all aspects of 
the chemical’s life cycle including production, supply chain, product use, and disposal (L.S.  
Haug, Huber, Becher, & Thomsen, 2011; Houde et al., 2011; Kudo & Kawashima, 2003; Liu et 
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al., 2017). PFCSs are generally water-soluble and as a result are often detected in drinking water 
(L.S.  Haug et al., 2011; Post, Cohn, & Cooper, 2012; Tittlemier et al., 2007). PFCSs have also 
been detected in measurable background levels in animal and human tissue and serum samples 
on nearly every continent including some remote locations (Hanssen, Röllin, Odland, Moe, & 
Sandanger, 2010; Kannan, Corsolini, Falandysz, Fillmann, & Kumar, 2004).  The most common 
PFCs detected in environmental and human samples are PFOS, PFOA, PFNA, and PFHxS  
(Kannan et al., 2004; Paul et al., 2009; Steenland, Tinker, Frisbee, Ducatman, & Vaccarino, 
2009). Other PFCs detected in human tissue samples include perfluorooctane sulfonamide 
(PFOSA), 2-(N-methyl-perfluorooctane sulfonamide) acetic acid (Me-PFOSA-AcOH), 2-(N-
ethylperfluorooctane sulfonamide) acetic acid (Et-PFOSA-AcOH or PFOSAA), 
perfluoroheptanoic acid (PFHpA), perfluorodecanoic acid (PFDeA or PFDA), 
perfluoroundecanoic acid (PFUA), perfluorododecanoic acid (PFDoA), perfluoropentanoic acid 
(PFPeA), perfluorohexanoic acid (PFHxA), and perfluorobutanesulfonic acid (PFBS) (USEPA, 
2009).   
Studies in experimental animals indicate that PFCs adversely affect liver, kidney, and 
immune system function. Laboratory studies of rats show that exposure to PFCs is associated 
with renal hypertrophy and histopathologic changes indicative of renal microvascular disease 
(Cui, Zhou, Liao, Fu, & Jiang, 2009). Similar studies in other rodents and primates show that 
PFC toxicity impairs liver function (Post et al., 2012; Rosen et al., 2010; Wolf, Zehr, Schmid, 
Lau, & Abbott, 2010). In humans, PFCs are associated with various diseases and metabolic 
abnormalities including chronic kidney disease (Shankar A., Xiao J., & Ducatman A., 2011), 
elevated cholesterol levels (J.W. Nelson, E. E.  Hatch, & T.F. Webster, 2010; Sakr, Leonard, 
Kreckmann, Slade, & Cullen, 2007; Steenland et al., 2009), insulin resistance and metabolic 
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syndrome (Lin, Chen, Lin, & Lin, 2009), and liver dysfunction (Gleason, Post, & Fagliano, 
2015). The study of PFC concentrations in human blood serum is relatively new. As such there is 
little information on exposure limits in various countries. Wilhelm et al., (2009) suggested the 
following reference values for internal contamination with some PFCs in Germany: for PFOA 
10μg/L for the general population; and for PFOS, 10 μg/L for children of school age, 15 μg/L for 
adult women, and 25 μg/L for men (Wilhelm, Angerer, Fromme, & Holzer, 2009). The European 
Food Safety Authority (EFSA), based on their assessment of PFC contamination in various food 
sources, also suggested a Tolerable Daily Intake (TDI) of 150 ng/kg b.w. per day for PFOS, and 
1.5 μg/kg b.w. per day for PFOA (European Food Safety Authority (EFSA), 2008).  
Studies suggest blood serum concentrations of PFCs among various populations differ 
worldwide. The EFSA found that the mean blood serum concentrations of various European 
populations were between 4 to 20 μg/L for PFOA; and 4 μg/L to 55 μg/L for PFOS (EFSA, 
2008). Kannan et al.,(2004)  studied PFC concentrations in nine different countries world-wide, 
namely the United States, Colombia, Brazil, Italy, Belgium, Poland, India, Malaysia, and Korea 
(Kannan et al., 2004).  They found that mean PFOS concentrations were highest in serum 
samples from the United States and Poland (greater than 30 ng/mL), followed by  mean 
concentrations in Japan, Korea, Malaysia, Belgium, and Brazil ( between 10 and 25 ng/mL), 
Italy and Colombia ( between 4 and 10 ng/mL), with India having the lowest concentration (1 
ng/mL) (Kannan et al., 2004). They also found that median concentrations of PFOA in Polish 
and Korean serum samples were 21 and 28ng/mL respectively, approximately two times greater 
than median concentrations for samples from the United States. Finally, median concentrations 
of PFHxS in samples from the United States, Korea, and Japan were in the range of 1.5-3 ng/mL 
higher than concentrations found in other countries (Kannan et al., 2004). Fromme et al., (2007) 
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also found that concentrations of PFOS, PFOA, AND PFHxS measured in blood samples from 
Germany were lower than that measured in a related study in the USA and Canada (Fromme et 
al., 2007). Another study also concluded that serum PFOS, PFOA and PFHxS concentrations of 
the US population are higher than that of residents of Europe, Asia, or Australia (Fromme et al., 
2009). A pilot study conducted in South Africa found concentrations of 1.6 μg/L PFOS, 1.3 μg/L 
PFOA, and 0.5 μg/L PFHxS in maternal blood, with the highest PFC concentrations observed 
among subjects who lived in urban and semi-urban areas, which were associated with the highest 
quality of living (Hanssen et al., 2010). On the other hand Kärrman et al.,(2006) found no 
significant differences in mean PFC concentrations among urban and rural residents in Australia 
(Kärrman et al., 2006).   
Considering that level of exposure to PFCs may be an important risk factor for adverse 
health effects, country of residence may be a key factor in examining the association between 
blood serum PFC concentrations and adverse health effects. Differences in levels of exposure to 
PFCs may translate into a difference in risk for associated diseases and health disorders.  
However, to the best of our knowledge, no studies have examined this phenomenon. In 2010, 
about 40 million foreign-born individuals (representing 13 percent of the total population) 
resided in the United States (Grieco et al., 2012).  Foreign-born individuals are a unique 
population that can be assessed to examine whether PFC serum concentrations increase with 
increasing years of residence in the United States, and whether that will be associated with 
increased risk for adverse health effects, including renal and liver dysfunction.    
Additionally, PFCs are typically detected as a mixture of two or three compounds in the 
environment and biological samples (Grandjean et al., 2012; Granum et al., 2013; Stein, 
McGovern, Pajak, Maglione, & Wolff, 2016). Even though individual PFCs have subtle 
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structural differences that affect their uptake and binding with human and animal tissue, and in 
turn result in different toxicity profiles (Post et al., 2012; Rosen et al., 2010), little is known 
about the adverse health effects of simultaneous exposure to these chemicals (Rappazzo, 
Coffman, & Hines, 2017). Most studies have examined the effects of exposure to these 
chemicals on an individual basis and not their combined or interactive effects on health 
outcomes.  By examining their combined effects, instead of one chemical at a time, it may be 
possible to identify any associations between simultaneous exposure to PFCs and adverse health 
effects more accurately. This will provide insight into understanding the biological mechanisms 
of pollutant toxicity to guide public health interventions. 
Study Purpose  
The overall aim of this study is to evaluate the association between long-term background 
exposures to selected PFCs and renal and liver function.  This study aims to fill the gaps in the 
understanding of how differences in exposure patterns to PFCs are associated with (1) Measures 
of renal function (as indicated by estimated glomerular filtration rate (eGFR); and (2) measures 
of liver function (as indicated by markers of liver toxicity; Alanine aminotransferase (ALT), γ-
glutamylytransferase (GGT) and total bilirubin). The study will answer the following research 
questions, using data available from the National Health and Nutritional Examination Survey 
(Centers for Disease Control, 2010). 
Research Questions   
1. Do PFC serum concentrations significantly differ between native- and foreign-born U.S. 
residents?  
Among foreign-born U.S. residents: 
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2. Do PFC serum concentrations increase with increasing length of residence in the U.S?  
3. Are there significant associations between PFC serum concentrations and kidney function 
[as measured by estimated glomerular filtration rate (eGFR)]? 
a. Does length of residence in the U.S have a significant moderating impact on the 
association between selected PFCs and kidney function? 
4. Are there significant associations between PFC serum concentrations and liver function 
[as measured by Alanine aminotransferase (ALT), γ-glutamylytransferase (GGT) and 
total bilirubin]? 
a. Does length of residence in the U.S have a significant moderating impact on any 
observed associations PFC serum concentrations and liver function indicators?    
5. Considering that background exposure to the selected PFCs occurs concurrently, what is 
the association between the joint exposures of multiple PFCs and either kidney and or 
liver function? 
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Chapter II: Literature Review 
Toxicology of PFCs 
Sources of Exposure: PFCs are released into the environment through degradation of precursors 
and throughout the life cycle of products made with PFCs (Lindstrom et al., 2011a). 
Manufacturing facilities, waste treatment plants, military bases, and landfills can also be point 
sources for PFCs in the soil (Filipovic, Woldegiorgis, Norström, et al., 2015; Xiao, Simcik, 
Halbach, & Gulliver, 2015), and outdoor air (Ahrens, Shoeib, et al., 2011). Soil contamination 
can also occur from the application of PFC-contaminated biosolids as an amendment to soils as 
fertilizers (Lindstrom, Strynar, & Libelo, 2011; USEPA, 2011; Washington, Yoo, Ellington, 
Jenkins, & Libelo, 2010; Yoo, Washington, Ellington, Jenkins, & Neill, 2010). Because of the 
use of PFCs in manufacturing carpets, upholstered furniture, and other textiles, PFCs have been 
detected in dust from indoor spaces. Exposure to PFCs and their precursors can occur through 
inhalation of contaminated air (Fraser et al., 2013; L. S. Haug et al., 2010; Langer, Dreyer, & 
Ebinghaus, 2010; Shoeib, Harner, & Vlahos, 2006), and through ingestion of dust and dirt 
particles containing PFCs. Dermal exposure can also occur through skin contact with products 
that have been treated with PFCs or its precursor compounds (Goosey E, 2011; Haug L.S., Huber 
S., Schlabach M., Becher G., & Thomsen C., 2011). This is of particular concern in children 
because exposure can occur if children touch PFC-treated products and put their hands in their 
mouth, or if an infant sucks on such products (Stahl, Mattern, & Brunn, 2011). However, despite 
their ubiquitous presence in the environment, the predominant route of exposure to PFCs occurs 
through the ingestion of contaminated food and/or drinking water (Stahl et al., 2011; Tittlemier 
et al., 2007; Trudel D. et al., 2008).  One study to estimated that Canadians ingest on average 
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250ng of PFOA and PFOS daily. (Tittlemier et al., 2007). In a similar study in Germany, 
Fromme at al., (2007) estimated that study subjects were exposed to 1.8 ng/kg/BW and 3.9 
ng/kg/BW of PFOS and PFOA respectively on a daily basis (Fromme H. et al., 2007).   
Uptake and Distribution: Laboratory studies show that PFCs are well-absorbed and assimilated 
following oral and inhalation exposure, and to a lesser extent following dermal exposure. In 
studies of male rats, ninety-five percent of radioactively labeled PFOS dose (4.3 mg/kg BW) and 
93% of labeled PFOA dose (11 mg/kg BW) were resorbed within twenty-four hours (Gibson & 
Johnson, 1979). Kennedy et al.,(1986) found that mean blood concentration of ammonium 
perfluorooctanoate (APFO) in male rats was 108 mg/L after 10 inhalations of 84 mg/m3 of 
APFO (Kennedy, Hall, Brittelli, Barnes, & Chen, 1986). PFOS and PFOA are weakly lipophilic, 
water soluble, and bind preferentially to proteins (Stahl et al., 2011). They usually bind with 
albumin (Han, Snow, Kemper, & Jepson, 2003; Völkel et al., 2007), or β-lipoproteins and fatty 
acid binding proteins in the liver (L-FABP) (Lübker, Hansen, Bass, Butenhoff, & Seacat, 2002). 
As such, they are usually detected as accumulated in the liver, blood serum, and kidneys, 
although small concentrations can be detected in other tissues (Stahl et al., 2011).   
Elimination: PFOA and PFOS are not metabolized in mammals and can only be eliminated 
through excretion once they have been absorbed into the body (Kudo & Kawashima, 2003). 
They are eliminated slowly in humans and can persist for several years.  Harada et al.,(2005) 
determined renal clearance values of 0.012 mL/kg/day for men and 0.019 mL/kg/day for women 
for PFOS excreted in urine (Harada et al., 2005). In the same study, PFOA clearance was 0.033 
mL/kg/day for men and 0.0027 mL/kg/day for women (Harada et al., 2005). Due to this low 
renal clearance of PFOA and PFOS, they have a long half-life when compared with other similar 
chemicals (Stahl et al., 2011). In studies carried out among occupationally exposed workers, 
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PFCs had a relatively long half-life with a mean time of 5.4 years for PFOS, 3.8 years for PFOA, 
and 8.5 years for PFHxS (Olsen et al., 2007). In a study conducted in Germany among 
community residents who had been exposed to PFC-contaminated drinking water, plasma PFOA 
concentrations were 4.5 to 8.3 times concentrations of residents in unaffected neighboring towns. 
On follow-up one year later, geometric mean PFOA concentrations had decreased by an average 
of 10% for men, 17% for women, and 20% for children (Hölzer et al., 2009). 
Perfluorooctanoic acid (PFOA) 
Chemical and Physical Properties: Perfluorooctanoic acid (PFOA) is a completely fluorinated   
8-carbon organic synthetic acid that has a carboxylic acid end group and exists as both linear and 
branched isomers (Naile, Garrison, Avants, & Washington, 2016) (Figure 1). It is one of the 
most common PFCs and has been identified as an environmental pollutant (Danish 
Environmental Protection Agency, 2013). It has liquid repellant properties which makes it a 
suitable raw material for water-resistant consumer products such as paper plates and cups 
(Vierke, Staude, Biegel-Engler, Drost, & Schulte, 2012).  PFOA forms aqueous micelles which 
attract positively charged surfaces (USEPA, 2016).  Due to its strong bonds, it is stable in 
environmental media and resists breakdown by environmental degradation processes such as 
biodegradation, photolysis, and hydrolysis both in the natural environment and under laboratory 
conditions (National Center for Biotechnology Information (NCBI), 2018; USEPA, 2016b; 
Vierke et al., 2012; Winquist & Steenland, 2014). The breakdown process ends once PFOA is 
formed, whether synthetically or as the byproduct of production or breakdown of other 
compounds. As a result, PFOA persists throughout the environment, in the air, soil sediments 
and water systems (Koskela et al., 2016), and in blood and tissue samples of animals and humans 
(USEPA, 2016b; Vierke et al., 2012; Winquist & Steenland, 2014). 
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Use and Manufacturing: PFOA can be produced through an industrial process or is the 
byproduct of degradation of other synthetic organic products (Koskela et al., 2016; Vierke et al., 
2012).  It can be produced from the breakdown of an ammonium salt, ammonium 
perfluorooctanoate (APFO), which is used as an emulsifier during polymerization in 
fluoropolymer production (C. Lau, Anitole, Hodes, et al., 2007).  APFO is not consumed during 
the polymerization process, and disassociates to create a PFOA anion which is then ionized in 
water to form the acid (USEPA, 2016b). Under certain environmental conditions, other PFCs can 
also degrade to create PFOA (Vierke et al., 2012). This is usually observed when a minimum of 
seven perfluorinated carbon atoms which are connected to various functional groups in a carbon 
chain undergo a breakdown reaction. Examples of such PFCs include fluorotelomer alcohols 
(FTOHs), polyfluoroalkyl phosphoric Acid (PAPs), and polyfluorinated iodides (PFIs) (Vierke et 
al., 2012).  
Another common way is to manufacture PFOA is by telomerization, which is the reaction of 
tetrafluoroethylene and fluorine-bearing chemicals to produce fluorinated intermediates to PFOA 
and perfluorinated iodides (PFIs). The telomerization process results in the production of linear-
chained PFOA molecules (Vierke et al., 2012).  PFOA is also produced by Electro-Chemical 
Fluorination (ECF), which involves the passage of electric current through a solution of 
hydrogen fluoride and organic feedstock to produce carbon-hydrogen molecules that are both 
linear and branched isomers. The carbon-hydrogen bonds are then replaced with carbon-fluorine 
bonds to create PFOA (USEPA, 2016b).  Other sources of PFOA include the atmospheric 
degradation or transformation of PFOA precursors such as fluorotelomer alcohols, olefins, and 
perfluoroalkyl sulfonamide substances (Wallington et al., 2006).  
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 The use of PFOA in industrial products started in the 1940s (Association of State and Territorial 
Solid Waste Management Officials (Association of State and Territorial Solid Waste Mangement 
Officials (ASTSWMO), 2015). PFOA is used to produce fluoropolymers (USEPA, 2016b; 
Winquist & Steenland, 2014). It’s heat-, water- and stain-resistant properties make it valuable as 
a surfactant in many industrial and consumer products. For example, it is applied to Teflon-based 
products because it helps prevent Teflon from boiling.  It serves as an emulsifier for 
fluoropolymers which act as surface protectants in carpets, fabrics, cookware, outdoor apparel, 
clothing, paper plates, paper, cardboard packaging, electrical wire casings, ski wax, paints, 
photographic film additives, the textile finishing industry, cleaning agents, tile, stone, leather, 
and fire-fighting foams (Renner, 2001; USEPA, 2016b; Vierke et al., 2012). Therefore, products 
like Teflon, Gore-Tex, Stainmaster, and Scotchgard are likely to contain PFOA (Danish EPA, 
2013). The presence of PFOA in the environment is the result of contamination from 
manufacturing and industrial plants (Association of State and Territorial Solid Waste 
Mangement Officials (ASTSWMO), 2015; Lindstrom et al., 2011), as well as its ubiquitous use 
in commercial and household products. PFOA is detected around the globe under various 
environmental conditions (Kannan et al., 2004; Sinclair, Mayack, Roblee, Yamashita, & Kannan, 
2006).  
Toxicokinetics: Once absorbed into the body, PFOA is distributed by binding with plasma 
proteins (Cui et al., 2009; C. Lau, Anitole, C., et al., 2007). Postmortem studies found PFOA in 
human tissue, including the lung, kidney, and bone (USEPA, 2016b). PFOA is not lipophilic and 
does not metabolize, and it is not necessarily genotoxic to the human body (Steenland et al., 
2009). Laboratory studies conducted in rodents show PFOA is detectable in plasma within a half 
hour after nasal exposure (Cui et al., 2009; Gibson & Johnson, 1979; Hinderliter, DeLorme, & 
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Kennedy, 2006). When ingested, it can take up to 2 to 10 hours to be absorbed in rats 
(Hinderliter, Han, Kennedy, & Butenhoff, 2006; Karrman et al., 2007). Fasting causes PFOA 
absorption at higher rates (Karrman et al., 2007; Sibinski L.J., 1987). Differences in absorption 
rates are detectable by sex, where female rats absorb PFOA faster (1 hour) compared to male rats 
(10 hours) when ingested (S. C. Chang et al., 2008). Franko et al., (2012) found that 24% of a 
single dose of PFOA is absorbed by the human skin after 24 hours, with the rate of dermal 
absorption being dependent on skin ph (Franko, Meade, Frasch, Barbero, & Anderson, 2012). 
PFOA can also enter the placenta and traces are found in breast milk (USEPA, 2016b). 
Laboratory research in rats, showed that breast milk contained 10 times less PFOA than the 
maternal blood plasma concentrations (Hinderliter, Han, et al., 2006). However, the PFOA 
concentrations found in the milk equaled the amount of PFOA concentrations found in the blood 
plasma of the nursing rat (Hinderliter, Han, et al., 2006).   
In the body, PFOA is transported to the blood, kidney, lungs, skin, pancreas, spleen, 
thymus, heart, testes, epididymal fat, fat pads, brain, muscle, bones, and bone marrow (S. C. 
Chang et al., 2008; Koskela et al., 2016).  Higher concentrations are found in in the liver and 
plasma (Houde et al., 2011; Kudo & Kawashima, 2003) compared to other areas of the body. 
The plasma aids to absorb PFOA and its travel into the soft tissue (Kerstner-Wood, Coward, & 
Gorman, 2003). PFOA has hepatotoxic effects that negatively impact the behavior and kinetics 
of enzymatic reactions (USEPA, 2016b; Yan et al., 2015). Exposure to PFOA leads to the 
activation of the receptor protein, Peroxisome proliferator-activated receptor alpha (PPAR-
alpha), in the liver (Yan et al., 2015). Proliferation of PPAR-alpha agitates nuclear receptors 
Peroxisome proliferator-activated receptor (PPAR), Constitutive androstane receptor (CAR), 
Farnesoid X receptor (FXR), and Pregnane X receptor (PXR) to produce negative effects on 
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human liver carcinoma cells (HepG2). The primary function of the nuclear receptors is to detect 
the presence of foreign toxic substances, and then increase the cellular response of proteins 
involved in the process of detoxification and clearance of such substances (Fiorucci, Zampella, 
& Distrutti, 2012; Kliewer, Goodwin, & Willson, 2002; Ueda et al., 2002). 
In the body, PFOA is not metabolized and does not undergo further processes until it is 
cleared through urine and feces (Butenhoff, Chang, Ehresman, & York, 2009; Conder, Hoke, De 
Wolf, Russell, & Buck, 2008; Harada et al., 2005). This process is slow and can take between 2 
to 4 years in humans, once exposure ceases (Harada et al., 2005; Olsen et al., 2007). Differences 
in the rate of renal clearance are detected between species and sex (Kudo & Kawashima, 2003). 
Rats clear PFOA through renal cavities at an average rate of 1.35 mL/hr/kg and bronchial tract at 
a rate of 0.12 mL/hr/kg (Conder et al., 2008). Renal elimination of PFOA from the system 
showed gender variances in adult rats (Worley & Fisher, 2015). In humans, hormonal differences 
among males and females affect the function of organic anion transporters that manage 
absorption and clearance of PFOA in the body (Worley & Fisher, 2015). In laboratory studies, 
female rats cleared PFOA through urine, while males cleared the PFOA in both urine and bile. 
When rats were given PFOA through IV, females cleared nearly the full dose within 24 hours, 
compared to the 20% cleared by males within the same time, which suggested that female rats 
excreted PFOA 44 times faster than males (USEPA, 2005).  
Human Health Effects: The vast majority of the global population have detectable levels of 
PFOA in their system, usually at very low levels, an average of 5 parts per billion (Steenland, 
Fletcher, & Savitz, 2010). Approximately 98% of the U.S population have detectable traces of 
PFOA in their urine (Steenland et al., 2010). Available studies suggest that at high exposure 
concentrations, PFOA can produce negative health outcomes in humans (Naile et al., 2016; Post 
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et al., 2012). Yet there is no consensus on the health effects of continuous background exposure 
to these chemicals (Post et al., 2012). Various studies have examined the association between 
PFOA exposure and various health outcomes among factory workers, who have historically high 
exposures, and the general population. Numerous studies have documented a positive association 
between PFOA and high cholesterol in occupational settings (Costa, Sartori, & Consonni, 2009; 
Olsen, Burris, Burlew, & Mandel, 2000; Olsen & Zobel, 2007; Sakr et al., 2007; Steenland, 
Zhao, & Winquist, 2015) and in high exposure communities (Fitz-Simon et al., 2013; Frisbee et 
al., 2010; Steenland et al., 2009; Winquist & Steenland, 2014). The results remained significant 
even after controlling for cholesterol lowering medications (Steenland et al., 2015; Winquist & 
Steenland, 2014). In the occupational studies, the mean serum levels ranged between 0.4 -  > 12 
μg/mL, while in the general population studies, the mean serum levels ranged between 0.002–
0.007 μg/ml (Eriksen et al., 2013; Fisher, Arbuckle, Wade, & Haines, 2013; Geiger et al., 2014; 
Starling et al., 2014). 
PFOA is also associated with adverse fertility, pregnancy, and birth outcomes.  It has been linked 
to tumors and neonatal death in rats (Steenland et al., 2010).   PFOA is found in the umbilical 
cord blood, placenta, and amniotic fluid of pregnant individuals (USEPA, 2016b), and has been 
linked with pregnancy-induced hypertension and preeclampsia (Darrow et al., 2016; USEPA, 
2016b). Additionally, infants are exposed to PFOA in the breast milk of exposed mothers 
(USEPA, 2016b; Völkel et al., 2007).  Johnson et al (2014) conducted a meta-analysis of 
available studies and found that a 1-ng/mL increase in maternal or cord serum PFOA levels was 
associated with a 0.1 (95% CI: –0.1, –0.02) cm decrease in birth length, a 0.01 (95% CI: –0.03, 
0.01) decrease in ponderal index, a 0.03 (95% CI: –0.1, 0.01) cm decrease in head 
circumference, and a mean birth weight reduction of –18.9 g (95% CI: –29.8, –7.9) (Starling et 
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al., 2014).   Wu et al., (2012) surveyed a Chinese district near an electronic recycling facility to 
examine the relationship between PFOA and neonatal health. Participants included the district’s 
pregnant residents and facility employees who had higher levels of PFOA than the control group. 
They found that higher concentrations of PFOA in pregnant mothers resulted in shorter 
gestational age, and lower weight, length, and Apgar scores at birth (Wu et al., 2012).   Lam et 
al., (2015), also found that high concentration of PFOA during gestation is associated with 
reduced neonatal development and growth outcomes (Lam et al., 2014).  On the other hand, in 
studies of a community with high exposures to PFOA, the researchers did not observe any 
associations between PFOA and either birth weight among term births or the risk of low birth 
weight among all (singleton) births (Darrow, Stein, & Steenland, 2013; Nolan, Nolan, Shofer, 
Rodway, & Emmett, 2009; Savitz, Stein, Bartell, et al., 2012; Savitz, Stein, Elston, et al., 2012). 
Also, while studies suggest an association between increase in PFOA levels and decreases in 
female fertility (Fei, McLaughlin, Lipworth, & Olsen, 2009; Velez, Arbuckle, & Fraser, 2015), 
comparable results have not been demonstrated in males (Joensen et al., 2009). 
Studies also suggest that PFOA negatively impacts metabolism, homeostasis, and cellular 
differentiation (Naile et al., 2016). PFOA is toxic to the liver, endocrine and immune system 
(Steenland et al., 2010) and alters cyclins that regulate cell control (Buhrke et al., 2015). Studies 
indicate that increasing concentrations of PFOA were associated with significant increase in total 
bilirubin, which is an important indicator of liver function (Costa et al., 2009; Olsen & Zobel, 
2007; Sakr et al., 2007). On the other hand, the C8 Health Project observed a U-shaped 
exposure-response pattern for serum bilirubin among the residents of a community with high 
PFOA exposure, which was similar to the inverse associations observed in occupational exposed 
cohorts (Gallo et al., 2012).  Darrow et al., (2015) also found that PFOA was associated with 
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hepatocellular damage and increase in serum levels of alanine aminotransferase (ALT), gamma-
glutamyl transpeptidase (GGT), and total bilirubin levels. However, other studies have suggested 
that the association between PFOA and AST, ALT, and GGT might be moderated by the 
presence of covariates such as BMI, use of lipid lowering medications, and triglycerides in the 
models (Costa et al., 2009; Olsen et al., 2000; Olsen, Church, et al., 2003; Olsen & Zobel, 2007; 
Sakr et al., 2007). 
Buhrke et al., (2015) found that PFOA negatively affects signaling pathways for various receptor 
proteins including PPAR-alpha, estrogen receptor (ER-alpha), peroxisome proliferator-activated 
receptor gamma (PPARG), and hepatocyte nuclear factor 4 alpha (HNF4a) (Buhrke et al., 2015). 
Steenland, et al., (2013) found significant positive associations in the relationship between PFOA 
and ulcerative colitis in exposed individuals (Steenland, Zhao, Winquist, & Parks, 2013). 
Tubular resorption of PFOA in the kidney allows PFOA to travel and exit the body. As a result, 
exposure to high PFOA concentrations can negatively affect kidney function (USEPA, 2016b). 
Numerous studies have demonstrated that increasing concentrations of PFOA are associated with 
increased concentration of uric acid in the urine of exposed individuals (Shankar A. et al., 2011; 
Steenland et al., 2010). Other studies among workers exposed to high PFOA concentrations 
shows that increasing PFOA serum concentrations were associated with reduced kidney function 
as measured by estimated glomerular filtration (eGFR) rates (Costa et al., 2009; USEPA, 2016b).  
Some studies demonstrate a relationship between PFOA and some types of cancer such as 
prostate, kidney, and testicular cancer (Barry, Winquist, & Steenland, 2013; V. M. Vieira et al., 
2013). Steenland et al., (2012) found that exposure to high concentrations of PFOA was 
associated with ovarian cancer (Steenland & Woskie, 2012). Ma et al., (2015) found that PFOA 
stimulates cell migration, and invasion in endometrial cancer by promoting the down-regulation 
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of the tumor suppressor gene, E-cadherin (Ma et al., 2016). On the other hand, studies of 
occupational cohorts did not find an increased risk of kidney or testicular cancer (Raleigh et al., 
2014; Steenland & Woskie, 2012). Additionally, studies conducted among populations exposed 
to background PFOA concentration levels did not find any significant associations between 
increasing concentrations and colorectal, breast, prostate, bladder, or liver cancer (Bonefeld-
Jørgensen, Long, Fredslund, Bossi, & Olsen, 2014; Hardell et al., 2014; Innes, Wimsatt, Frisbee, 
& Ducatman, 2014). 
Perfluorooctane sulfonic acid (PFOS) 
Chemical and Physical Properties: Perfluorooctane sulfonic acid (PFOS) is an 8-carbon 
organic compound with a sulfonate end chain group (Figure 2). It is a strong acid that is 
generally present in solution as a Perfluorooctane sulfonic acid anion with a mixture of linear 
(70%) and branched chain isomers (30%) (Beesoon & Martin, 2015; De Silva & Mabury, 2004). 
It is a very stable compound that has a low vapor pressure and is solid at room temperature 
(USEPA, 2016a).  PFOS resists breakdown by natural degradation processes and can be 
transported for long distances through advection, dispersion, and sorption to particulate matter 
(USEPA, 2016a).   It can be detected in ambient air and in water bodies all over the world, even 
in remote locations like the Arctic (Ahrens, Yeung, et al., 2011; Lindstrom et al., 2011). 
Use and Manufacturing: PFOS is produced commercially from perfluorooctanesulfonyl 
fluoride (POSF), an intermediate used to synthesize other fluorochemicals, and by the 
environmental degradation of other POSF-derived fluorochemicals. Due to its water- and lipid-
resistant properties, PFOS was used as a waterproofing or stain-resistant agent in carpets, 
leathers, textiles, upholstering, and paper packaging (Renner, 2001; USEPA, 2016a). It is also 
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used in the production of firefighting foam, and aviation fluid due to its heat resistant properties 
(USEPA, 2016a).  
With the cessation of PFOS production in the United States, the concentration of PFOS in 
humans and wildlife have decreased, even though significant concentrations can be measured in 
animal tissue and environmental samples worldwide (USEPA, 2016a). Efforts are ongoing to 
develop replacement products for PFOS and other PFCs that do have similar range of toxicity, 
and bioaccumulation issues, but suitable replacement products have not been developed 
(USEPA, 2016a). As a result, some PFOS-related chemicals continue to be used until 
alternatives can be found, such as in aviation fluid, photo microlithography, and film processing 
(USEPA, 2016a). Additionally, existing stocks and products already in the United States before 
rules stopping PFOS manufacture took effect in 2002, can still be used without any restrictions 
(USEPA, 2009, 2016a). 
Toxicokinetics: PFOS is absorbed from the gastrointestinal tract and distributed to the tissues 
and organs (Cui et al., 2009; Curran et al., 2008), with high concentrations found in the liver, 
kidneys, and lungs (Perez et al., 2013).  It binds with serum proteins such as albumin (Weiss et 
al., 2009), immunoglobulins and transferrin (Kerstner-Wood et al., 2003) and displaces other 
chemicals that normally occupy the binding sites (Beesoon & Martin, 2015). PFOS also binds 
with receptors (e.g. peroxisome proliferator- activated receptor-alpha [PPARα]), transport 
proteins (e.g., transthyretin [TTR]), fatty acid binding proteins, and enzymes  (Lübker et al., 
2002; Weiss et al., 2009; Wolf et al., 2010). This causes a change in the conformation of the 
serum proteins and affect their affinity for endogenous compounds they normally transport 
(Beesoon & Martin, 2015; Kerstner-Wood et al., 2003).   
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A portion of PFOS absorbed in the body is excreted in bile (S. C. Chang et al., 2008; Harada et 
al., 2005). Thus, the concentration of PFOS in fecal matter include both unabsorbed material and 
that discharged with bile (S. C. Chang et al., 2008; Harada et al., 2005). Studies suggest that 
PFOS is transferred to the fetus during pregnancy (S. C. Chang et al., 2008; Lübker et al., 2002), 
as well as through breastmilk during lactation (Bjerregaard-Olesen et al., 2017; Hanssen et al., 
2010). The arithmetic mean half-life in humans for occupationally exposed workers was 5.4 
years (95% CI=3.9, 6.9) (Olsen et al., 2007).  
Human Health Effects: Laboratory studies of rats shows that PFOS exposure leads to increases 
in liver weight, liver hypertrophy, and a decrease in serum cholesterol and triglyceride levels 
(Elcombe et al., 2012; Seacat et al., 2003). Exposure to PFOS also led to decreased body weight 
and lipid metabolism defects (F. Wang, Liu, Jin, Wang, & Ma, 2015). Additionally, increasing 
PFOS exposure levels were associated with decrease in glomerular filtration rates, as well as 
reduced serum thyroid hormone levels (S. C. Chang et al., 2008). PFOS exposure also appears to 
have negative reproductive effects in rats such as decreased sperm count and reduced birth 
weight and size (C. Lau, Anitole, C., et al., 2007). 
In humans, increases in PFOS serum concentrations are associated with increases in total 
cholesterol level (Olsen et al., 2000; Olsen & Zobel, 2007), as well as hypercholesterolemia 
(defined as cholesterol > 240 mg/dL) (Fisher et al., 2013; Steenland et al., 2009).  PFOS also has 
a significant positive association with increased serum ALT values (Gallo et al., 2012; Lin et al., 
2009). However, Gallo et al., (2012) did not find significant associations between PFOS and 
increased serum cholesterol. Shankar et al., (2011) found a significantly positive association 
between increasing concentrations of PFOS and chronic kidney disease (as defined as an eGFR 
of < 60 mL/min/1.73 m2) (Shankar A. et al., 2011). Watkins et al., (2013) found that for every 
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unit increase in PFOS concentration, eGFR decreased by 1.10 mL/min/1.73 m2 (95% CI: −1.66 
to −0.53) (Watkins et al., 2013). Other studies have also found a significant positive association 
between PFOS and increase in uric acid concentrations (Steenland et al., 2010). 
PFOS is also associated with adverse pregnancy and birth outcomes among exposed individuals. 
Numerous studies found that increases in maternal serum/cord PFOS concentrations were 
associated with birth weight deficits (Darrow et al., 2013; Savitz, Stein, Elston, et al., 2012; 
USEPA, 2016a). Although a few of these studies showed some suggestion of dose-response 
relationships across different fetal growth measures (Fei et al., 2009; Maisonet et al., 2012), 
study limitations, including the potential for exposure misclassification, likely precluded the 
ability to adequately examine the exposure-response pattern. Other studies did not find 
significant associations between exposure to PFOS and negative birth outcomes (Fei et al., 2009; 
Hamm, Cherry, Chan, Martin, & Burstyn, 2010). 
Studies have shown an association between increasing PFOS serum concentrations and 
gestational diabetes (X. Wang et al., 2017), pre-eclampsia (Stein et al., 2016) and pregnancy-
induced hypertension (Darrow et al., 2013). PFOS exposure may also be associated with 
measures of fertility such as morphologically abnormal sperm and poor semen quality (Joensen 
et al., 2009), increased odds of infertility (Jorgensen et al., 2014). However, other studies did not 
find significant relationships between PFOS exposure and semen quality (Joensen et al., 2009; 
Vested et al., 2013). 
Some studies have evaluated that association between PFOS and immune function. Studies in 
children found that the antibody response (as measured by antibody titer) in children (up to 7 
years) after vaccination with one or more vaccines was decreased in relation to increasing 
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prenatal serum PFOS levels  (Grandjean et al., 2012; Granum et al., 2013). A study using 
NHANES data also found decreased rubella and mumps antibody concentrations in relation to 
serum PFOS concentration among 12–19-year-old children, especially among seropositive 
children (Stein et al., 2016). In adults, no associations were observed between PFOS exposure 
and antibody response to influenza vaccine (Looker et al., 2014).  
A few studies have examined the association between PFOS and cancer risk.  Alexander et al., 
(2003) found an increased risk of bladder cancer mortality with increasing PFOS exposure levels 
in a cohort of occupational exposed workers (Alexander, Olsen, Burris, Mandel, & Mandel, 
2003). On the other hand, a subsequent study to examine cancer incidence did not find any 
significant associations with PFOS exposure (Alexander & Olsen, 2007).   Eriksen et al., (2009) 
also did not find any significant associations between elevated bladder cancer risk and increasing 
PFOS concentrations in a Danish cohort (Eriksen et al., 2009). 
Perfluorohexane sulfonic acid (PFHxS)  
Chemical and Physical Properties: Perfluorohexane sulfonic acid (PFHxS) is 6 carbons in 
length with a sulfonate end chain group (Figure 3) (European Chemical Agency, 2017).  Samples 
of PFHxS are found, both in the environment and in organisms, as an aqueous mixture of 
perfluorohexanesulfonic acid (PFHxS), and its conjugate base perfluorohexanesulfonate 
(PFHxS-) (European Chemical Agency, 2017). This gives PFHxS both hydrophobic and 
hydrophilic properties and it forms multiple layers in an octanol-water mixture  (Conder et al., 
2008; European Chemical Agency, 2017).  Just like other PFCs, PFHxS resists chemical, thermal 
and biological degradation due to their strong carbon-fluorine bonds (Baran, 2001; Braunig et al., 
2017; Taniyasu, Yamashita, Yamazaki, Petrick, & Kannan, 2013). For instance, PFHxS resists 
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degradation by photolysis at high altitudes (Taniyasu et al., 2013). It is frequently found in soil 
and water near fire-fighting training, manufacturing plants and waste disposal sites areas 
following the historical use of PFHxS-containing foams, showing that it is persistent and does 
not undergo any abiotic or biotic degradation (Braunig et al., 2017; Filipovic, Woldegiorgis, 
Norstrom, et al., 2015).  PFHxS, along with PFOS and PFOA is the most frequently detected 
PFC in the general population in several countries, with a detection rate of greater than 98% 
(Bjerregaard-Olesen et al., 2017; Calafat, Wong, Kuklenyik, Reidy, & Needham, 2007). It is also 
present in umbilical cord blood samples and breast milk (Gutzkow et al., 2012; Karrman et al., 
2007). PFHxS, can undergo long-range environmental transport (Llorca et al., 2012; Lohmann, 
Breivik, Dachs, & Muir, 2007), and is transported over long geographical distances to remote 
areas by ocean currents and through the air (Llorca et al., 2012; Lohmann et al., 2007; Routti et 
al., 2017). As a result, PFHxS can be detected in the environmental and serum samples from 
remote areas (Llorca et al., 2012; Lohmann et al., 2007; Routti et al., 2017).  
Toxicokinetics: PFHxS is absorbed after oral and inhalation exposure, and to a lesser extent 
after dermal exposure (Stahl et al., 2011). Studies suggest that more than 50% of PFHxS is 
absorbed after oral exposure (Stahl et al., 2011), and it biomagnifies as we move up the food 
chain (Haukas, Berger, Hop, Gulliksen, & Gabrielsen, 2007; Houde et al., 2006; Riget, Bossi, 
Sonne, Vorkamp, & Dietz, 2013). PFHxS tends to accumulate in the liver, blood, lung, and 
kidney (European Chemical Agency, 2017; Olsen, Hansen, Stevenson, Burris, & Mandel, 2003; 
Perez et al., 2013). Pérez et al., (2013) conducted a study on the presence of PFCs in human 
organ/tissues and found that PFHxS was most frequently detected in the lung (32%), but the 
highest median concentrations were found in the kidney (18 μg/kg wwt.,) followed by the lung 
(5.7 μg/kg wwt.). 
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Compared to other PFCs, PFHxS has the highest half-life ever reported. Olsen et al., (2007) 
estimated the elimination half-life of PFHxS, PFOS and PFOA in the serum samples of 26 
retired among a cohort of occupationally exposed fluorochemical production workers from a 3M 
plant in Decatur, USA over a 5-year period.  They found that mean/geometric mean elimination 
half-lives for PFHxS, PFOS and PFOA were 8.5 years (95% CI 6.4 - 10.6)/7.3 years (95% CI 5.8 
- 9.2)/ (range: 2.2 y – 27 years), 5.4 years (95% CI 3.9 - 6.9)/4.8 years (95% CI 4.0 - 5.8)/ (range: 
2.4 – 21.7 years), and 3.8 years (95% CI 3.1 - 4.4)/3.5 years (95% CI 3.0 - 4.1)/ (range: 1.5 – 9.1 
years), respectively.   
In another study conducted among Chinese adults, the researchers examined the rate of 
elimination of a number of perfluorinated compounds (PFCs), including PFHxS.  They found 
that PFOS was excreted more efficiently than PFHxS, and major branched isomers were more 
efficiently excreted than the corresponding linear isomers of PFOS and PFOA. Furthermore, they 
found that that urine is an important pathway of excretion of perfluoroalkyl substances even 
though other routes of excretion likely contribute to the overall elimination. The estimated 
arithmetic mean (range) elimination half-lives for the female / male groups for PFHxS, PFOS 
and PFOA were 7.7 (2.3 - 13) / 3.5 (1.6 – 18.2) years, 6.2 (3.2 – 10) / 2.7 (1.6 – 12.1) years and 
2.1 (0.19 – 5.2) / 2.6 (0.06 - 14) years, respectively (Zhang, Beesoon, Zhu, & Martin, 2013).   
Human Health Effects: Numerous studies suggest an association between PFHxS and adverse 
health outcomes such as elevated serum cholesterol, and other lipids (Fisher et al., 2013; 
Steenland et al., 2009), and endocrine (Jain, 2013; Long, Ghisari, & Bonefeld-Jorgensen, 2013; 
Weiss et al., 2009; Wen, Lin, Su, Chen, & Lin, 2013) and immune system disrupting effects 
(Grandjean et al., 2012; Granum et al., 2013).  
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Studies suggest that PFHxS exposure has immunotoxic effects in children. Granum et al.,(2013) 
studied the association between PFHxS maternal serum levels and decreased immune response in 
children. They found that increasing quartiles of PFHxS were associated with decreased serum 
levels of anti-rubella antibodies and increased number of episodes of gastroenteritis at age 3 
(Granum et al., 2013). Grandjean et al., (2012) observed decreased immune response after 
tetanus vaccination at 7 years of age (Grandjean et al., 2012). Also, higher exposure 
concentrations of PFHxS was associated with an increased incidence of asthma among exposed 
children (Dong et al., 2013; Zhu et al., 2016). Dong et al., (2013) found an increased risk of 
being diagnosed with asthma for increasing quartile concentrations of PFHxS (OR: Q1 vs. Q4= 
3.83, 95% CI 2.11–6.93) among children aged 10–15 years, after controlling for sex, age, BMI, 
parental education, environmental tobacco smoke exposure, and month of survey. On the other 
hand, Humblet et al., (2014) did not find an increased risk of self-reported asthma for increasing 
serum concentrations of PFOA, PFHxS, or PFNA among a nationally representative sample of 
U.S. children aged 12–19 years in the NHANES (Humblet, Diaz-Ramirez, Balmes, Pinney, & 
Hiatt, 2014).  
Laboratory studies in rodents show that PFHxS exposure has adverse effects on the liver and 
nuclear receptors that regulate metabolism, and is associated with increasing serum levels of 
cholesterol, and other lipids (Bijland et al., 2011; Butenhoff et al., 2009; Das et al., 2017).  
Butenhoff et al., (2009) found that rats exposed to 10 mg/kg/d of PFHxS developed 
hepatocellular hypertrophy (56% increase in liver weight) after 42 days of exposure, as well as 
thyroid organ toxicity (Butenhoff et al., 2009).  Other studies suggested that exposure to PFHxS 
has adverse effects on thyroid hormones in Arctic birds (Nost et al., 2012) and polar bears 
(Bourgeon et al., 2017). Oral exposure to PFHxS affects rodent behavior and levels of brain 
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neuroproteins after at a critical period in brain development (Lee & Viberg, 2013). Other studies 
of rodents exposed to PFHxS did not find any negative treatment-related effects in the 
respiratory tract, heart, or gastrointestinal tract (Butenhoff et al., 2009; Hoberman & York, 
2003).    
Studies have also found significant associations between PFCs and biomarkers of renal and liver 
function. Lin et al., (2010) found that increasing serum concentrations of PFHxS was associated 
with increasing serum total bilirubin levels. Other studies found significant associations between 
serum lipid concentrations and PFHxS concentrations (Fisher et al., 2013; J.W.  Nelson, E.E. 
Hatch, & T.F. Webster, 2010). Watkins et al., (2013), and Emmett et al., (2006a) examined the 
association between biomarkers of renal function and elevated levels of PFOA in the water 
supply of a community living near a DuPont facility in West Virginia (Emmett et al., 2006; 
Watkins et al., 2013). Watkins et al., (2013) found that increasing PFOA, PFOS, PFNA, and 
PFHxS serum levels were associated with decreasing estimated glomerular filtration rates. They 
suggested that the association between serum perfluoroalkyl levels and estimated glomerular 
filtration rates may be a result of reverse causation because PFOA levels were not significantly 
associated with eGFR 3 or 10 years before commencement of the study (Watkins et al., 2013).  
On the other hand, Emmett et al., (2006a) did not find significant associations between blood 
urea nitrogen (BUN) or serum creatinine levels and serum PFOA levels.   
Studies have also found conflicting results on the association between background exposure 
levels of PFCs and reproductive hormones in men. Raymer et al., (2012) found significant 
associations between PFOA levels and free testosterone and LH levels, but not with other 
reproductive hormones. They did not find any significant associations between serum PFOS 
levels and the reproductive hormones (Raymer et al., 2012). Joensen et al., (2013) found that 
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increasing concentrations of PFOS was associated with decreasing concentrations of 
testosterone, free testosterone, and free androgen index levels (Joensen et al., 2013). On the other 
hand, other studies did not find significant associations between PFOA, PFOS, or PFHxS 
testosterone levels (Joensen et al., 2009; Specht et al., 2012).  
Perfluorononanoic acid (PFNA)  
Chemical and Physical Properties: Perfluorononanoic acid (PFNA) is nine-carbons in length, 
with a carboxylate end chain group (Figure 4) (De Silva & Mabury, 2004). Samples of PFNA 
can be found as mixture of multiple linear, iso-branched, and multiple branched isomers (De 
Silva & Mabury, 2004).  The branched isomers are more common near industrial sites and the 
linear isomer more common in remote areas (De Silva & Mabury, 2004).  PFNA can be formed 
from the biodegradation of Fluorotelomer alcohols (FTOH) in the environment (Henderson & 
Smith, 2007). It can also be produced directly under laboratory conditions during the oxidation 
of linear fluorotelomer olefin mixtures or the carboxylation of PFOA (Organization for 
Economic Cooperation and Development (OECD), 2002).  
Use and Manufacturing: Production of PFNA in the United States was stopped in 2000 due to 
concerns about their persistence in the environment. Although the levels in the PFNA in the 
environment and in humans are lower than those of PFOS or PFOA, the concentration of PFNA 
in the general population has increased over the years (Calafat, Kuklenyik, et al., 2007).  It is 
very stable due to the strength of its carbon-fluorine bonds, and resists breakdown by oxidation 
in the environment (Prevedouros, Cousins, Buck, & Korzeniowski, 2006). PFNA is used as a 
surfactant in many household and industrial products.  
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Toxicokinetics: The toxicity of PFNA is not as well-studied as PFOA, PFOS, or PFHxS. In 
available laboratory studies, exposure of rodents to PFNA resulted in adverse reproductive and 
developmental effects such as increased neonatal death, delayed eye opening and delayed 
puberty (Das et al., 2015); increased oxidative stress and apoptotic signaling in spleen cells 
(Fang, Gao, Xue, Zhang, & Wang, 2012); and increased apoptosis in the testes (Feng, Shi, Fang, 
Xu, & Dai, 2009).   
Current PFC Health Advisories  
Currently in the United States, there are no federal regulations or nationally recommended 
ambient water quality standards for PFOA and PFOS (USEPA, 2016a, 2016b). However, both 
national and international agencies have identified PFCs as potentially harmful substances due to 
their persistent, bioaccumulative, and toxic characteristics. The US EPA, and ATSDR and other 
national and international agencies have taken steps to set exposure limits, and maximum levels 
in drinking water and food items that would require reporting to the appropriate agency (USEPA, 
2016a, 2016b). In 2009, the U.S. Environmental Protection Agency (USEPA) produced a 
provisional health advisory (HA) 0.4 ng/mL for PFOA, and 0.2 ng/mL for PFOS in drinking 
water (USEPA, 2009).  These recommended levels reflect the amount of PFOA and PFOS that 
could cause adverse health effects in the short term (weeks to months) (USEPA, 2016a, 2016b).  
The EPA is in the process of developing lifetime exposure limits for exposure to PFOS and 
PFOA (USEPA, 2016a, 2016b). Also, the EPA has established drinking water monitoring 
requirements of 0.02 ng/mL, 0.04 ng/mL, 0.03 ng/mL, and 0.02 ng/mL for PFOA, PFOS, 
PFHxS, and PFNA respectively . The ATSDR has also derived an intermediate-duration oral 
maximum residue level (MRL) of 2x10-5 mg/kg/day (Butenhoff et al., 2009)  and   3x10-5 
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mg/kg/day (Seacat et al., 2003) for oral exposure to PFOA and PFOS respectively. Several 
international agencies have established guideline values for PFOA and PFOS (Appendix 1). 
Background concentrations of PFCs in the General Population in various countries 
Numerous studies have shown that significant geographic differences in mean serum PFC 
concentrations exist worldwide. Kannan et al., (2004) studied PFC concentrations in nine 
different countries world-wide, namely the United States, Colombia, Brazil, Italy, Belgium, 
Poland, India, Malaysia, and Korea. They found that mean PFOS concentrations were highest in 
serum samples from the United States and Poland (greater than 30 ng/mL), followed by mean 
concentrations from Japan, Korea, Malaysia, Belgium, and Brazil (between 10 and 25 ng/mL), 
Italy and Colombia (between 4 and 10 ng/mL), with India having the lowest concentration (1 
ng/mL). They also found that median concentrations of PFOA in Polish and Korean serum 
samples were 21 and 28ng/mL respectively, approximately two times greater than median 
concentrations for samples from the United States. Finally, median concentrations of PFHxS in 
samples from the United States, Korea, and Japan were in the range of 1.5-3 ng/mL higher than 
concentrations found in other countries (Kannan et al., 2004).  
Fromme et al., (2007) also found that concentrations of PFOS, PFOA, AND PFHxS measured in 
blood samples from Germany were lower than that measured in a related study in the USA and 
Canada (Fromme et al., 2007). Another study also concluded that serum PFOS, PFOA and 
PFHxS concentrations of the US population are higher than that of residents of Europe, Asia, or 
Australia (Fromme et al., 2009). A pilot study conducted in South Africa found concentrations of 
1.6 ng/mL PFOS, 1.3 ng/mL PFOA, and 0.5 ng/mL PFHxS in maternal blood, with the highest 
PFC concentrations observed among subjects who lived in urban and semi-urban areas, which 
were associated with the highest quality of living (Hanssen et al., 2010). On the other hand, 
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Kärrman et al., (2006) found no significant differences in mean PFC concentrations among urban 
and rural residents in Australia (Kärrman et al., 2006). 
Kärrman et al., (2006) examined concentrations of PFOA, PFOS, and PFHxS in blood samples 
(N=66) of participants who were resident in ten counties in the southern half and one county in 
the northern half of Sweden. The median (range) of PFOA, PFOS, and PFHxS were 2.5 ng/mL 
(1.9 - 3.3), 17.1 ng/mL (13 - 23), 1.5 ng/mL (0.4 - 28.4), respectively. The sample was not 
considered representative of the adult Swedish population because it was skewed in both age and 
gender distribution and had poor geographical distribution.  Ericson et al., (2007) examined the 
concentrations of 13 PFCs in whole-blood samples from residents in Catalonia, Spain (n=48). 
They determined any significant differences in serum concentrations based on gender and age. 
The reported median concentration (range) of PFOA, PFOS, and PFHxS 1.65 ng/mL (0.79 - 
3.13), 7.60 ng/mL (0.76 - 16.17) and 2.92 ng/mL (0.65 - 19.96) respectively.  PFHxS serum 
concentrations were significantly higher among the younger age group (25 ± 5 years) when 
compared to the older age group (55 ± 5 years). Additionally, PFHxS and PFOA serum 
concentrations were significantly higher (p < 0.05) among men than women (Ericson et al., 
2007).  
Hölzer et al., (2008) examined the concentrations of 6 PFCs in PFC-contaminated drinking 
water, and blood samples of residents of Arnsberg, Germany, and compared the concentrations 
to two reference areas, Siegen and Brilon. The exposed community, and reference communities 
were similar in terms of age, height, body weight and sex distribution. The geometric mean 
blood concentration of PFHxS, PFOS, and PFOA in blood plasma (ng/mL) was higher among 
males in Arnsberg was than males in Brilon (2.5 vs. 2.2; 10.5 vs. 9.7; and 25.3 vs. 5.8, 
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respectively); children in Arnsberg than children in Siegen (1.2 vs. 0.8; 4.9 vs. 4.6, and 22.1 vs. 
4.8., respectively), and females in Arnsberg than females in Siegen (1.1 vs. 0.6; 5.8 vs. 5.2; and 
23.4 vs. 2.8., respectively). The differences in serum concentrations between Arnsberg and the 
respective reference communities was significant for all groups for PFHxS and PFOA and was 
significant between females for PFOS (p<0.05). In addition, concentrations of PFHxS, PFOS, 
and PFOA significantly increased for increasing age of participants (Hölzer et al., 2008).   
Holzer et al., (2008) also found that blood concentrations of PFHxS was significantly associated 
with consumption of drinking water (p = 0.066), male sex, age, and study area (all p<0.01); 
PFOS was significantly associated with age, male sex, region, and consumption of locally 
caught fish (all p<0.01) and inversely with BMI (p=0.02) (Hölzer et al., 2009).  
Several studies have used the U.S. NHANES to examine the distribution of PFC serum 
concentrations among a representative sample of U.S. residents, and their association with 
various health outcomes. Lin et al., (2009) examined the association between PFCs and 
metabolic syndrome among 474 adolescents (12 – 20 years) and 969 adults (> 20 years) using 
the 1999-2000 and 2003-2004 NHANES. The arithmetic mean ± SE (ng/mL) among adolescents 
and adults were respectively 0.95 ± 0.10 and 0.60 ± 0.04 for PFHxS; 3.11 ± 0.05 and 1.51 ± 0.05 
for PFOS; and 3.19 ± 0.04 and 1.48 ± 0.04 for PFOA (Lin et al., 2009).  Hoffman et al., (2010) 
found that median (ng/mL) PFHxS, PFOS and PFOA serum concentrations in the 1999-2000 and 
2003-2004 NHANES were respectively 2.2, 22.6 and 4.4 respectively among children 12-15 
years of age (n = 571) (Hoffman, Webster, Weisskopf, Weinberg, & Vieira, 2010). Nelson et al., 
(2010) also found that median (ng/mL) concentrations of PFHxS, PFOS and PFOA were 1.8, 
21.0, and 3.9, respectively among NHANES participants 12 years and older in the 2003-2004 
survey year (J.W. Nelson et al., 2010).  
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Fromme et al., (2010) monitored the concentration of several perfluorinated compounds in a 
cohort of pregnant women over a nearly 2-year period (December 2007 -October 2009) in 
Munich, Germany. They measured concentrations in samples of maternal blood during 
pregnancy and six months after delivery (n = 47), in umbilical cord blood and in the blood of 
infants six and nineteen months after birth and in monthly breast milk samples. They found that 
the median maternal blood concentrations (ng/mL) during pregnancy, at delivery and six months 
after delivery for PFHxS, PFOS and PFOA were 0.5/0.5/0.3, 3.2/3.2/2.9, and 
2.4/1.9/1.5, respectively. The median concentrations (ng/mL) in cord blood serum, in the blood 
of infants six and nineteen months of age for PFHxS, PFOS and PFOA were 0.2/0.6/0.6 ng/mL, 
1.0/3.0/1.9 ng/mL, and 1.4/6.9/4.6 ng/mL, respectively. PFHxS was only detected in 6 out of 201 
(Range <0.02-0.3 ng/mL); PFOS was detected in 145 out of 201 [median (range) 0.04 (<0.3 - 
0.11) ng/mL]; and PFOA was detected in 4 out of 201 (Range <0.15 - 0.25 ng/mL) breast milk 
samples (Fromme et al., 2009). 
In a study of a cohort of pregnant Canadian women, the arithmetic mean concentrations (ng/mL) 
of PFHxS, PFOS and PFOA were 2.1, 9.0 and 2.1 respectively (Hamm et al., 2010). 
Jönsson et al., (2010) randomly selected a sample of 50 Swedish military conscripts (~18 years) 
and found that their median (range) (ng/mL) serum concentrations of PFHxS, PFOS and PFOA 
were 0.78 (0.38 - 2.5), 6.9 (3.7 - 19), and 1.9 (1.2 - 3.3), respectively (Jönsson et al., 2010). 
Hölzer et al., (2011) measured the levels of several PFCS in fish, drinking water and the blood 
plasma of anglers at Lake Möhne, Germany. PFHxS concentration levels were below the level of 
detection in the fish, while PFOA was detected in about 20% in of the fish and PFOS was 
detected in every fish that was caught.  The concentration levels of PFHxS, PFOS and PFOA in 
anglers ranged from 0.4 – 17 ng/mL (LOD = 0.1 ng/mL), 1.1 – 650 ng/mL and 2.1 – 170 ng/mL, 
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respectively. PFHxS were not detected in any tap water. The range of PFOS and PFOA 
concentration in the tap water was 0.011- 0.059 ng/mL and 0.020 - 0.047 ng/mL respectively. 
Hölzer et al., (2011) found that among the anglers, serum concentrations of PFHxS and PFOS 
had a significant positive association with age and the consumption of fish (p < 0.01); and 
concentrations of PFOA were significantly positively associated with age and concentration of 
PFOA in tap water (p < 0.01) (Hölzer et al., 2009). 
Kim et al., (2011) examined the concentrations of PFCs in the blood, fetal cord serum, and breast 
milk of pregnant Korean women. The median concentrations (IQR) (ng/mL) of PFHxS, PFOS 
and PFOA in blood serum, fetal cord serum and breast milk were 0.55 (0.46 -0.85), 0.34 (0.27-
0.51) and <0.05, respectively. The concentrations (ng/mL) in blood serum, fetal cord serum and 
breast milk were 2.93 (2.08-4.36), 1.26 (0.81-1.82), 0.06 (0.00-0.10) for PFOS  
and 1.46 (1.15-1.91), 1.15 (0.95-1.86) and 0.05 (0.03-0.07), for PFOA respectively (Kim et al., 
2011). Stein & Stavitz (2011) examined the cross-sectional association between serum PFCS 
concentrations and parent or self-report of doctor-diagnosed Attention Deficit Hyperactivity 
Disorder (ADHD) in children (5-18 years; n = 10456) living in the Mid-Ohio Valley in the U.S., 
a community exposed to PFOA through contaminated drinking water. The arithmetic mean ± SD 
(ng/mL) serum concentrations of PFHxS, PFOS and PFOA were 9.3 ± 13.7, 22.9 ± 12.5 and 66.3 
± 106.1, respectively (Stein & Savitz, 2011). 
Ji et al., (2012) examined the association between PFC blood serum concentrations and total 
thyroxine (T4) and thyroid stimulating hormone (TSH) levels in the general population in South 
Korea (n =633, > 12). The median concentrations (IQR) (ng/mL) of PFHxS, PFOS and PFOA 
were 1.51 (0.92 – 2.34), 7.0 (5.58 – 12.10) and 2.74 (2.04 – 3.64) respectively (Ji et al., 2012). 
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Toft et al., (2012) examined any associations between PFC exposure and male semen quality 
among 588 men from Greenland (n =196), Poland (n = 189) and Ukraine (n = 203). The highest 
levels of exposure (median, 33rd – 66th percentile (ng/mL)) were among the Greenlandic men 
than among men in Poland and Ukraine for PFHxS [2.2 (1.9-2.7), 1.2 (1.0 - 1.3), and 0.3 (0.3 - 
0.4) respectively]; PFOS [44.7 (38.8 - 56.1), 18.5 (15.4 - 21.2), and 7.6 (6.0 - 8.5) respectively]; 
PFOA [4.5 (4.2 - 5.2), 4.8 (4.2 - 5.6), and 1.3(1.0 - 1.6) respectively]; and PFNA [(1.7 (1.3 - 2.4), 
1.2 (1.0 - 1.3), and 1.0 (0.8  - 1.2) respectively] (Toft et al., 2012). 
Another study in Sweden examined the association between blood serum concentrations of 
several PFCs and diet and personal characteristics of adults (18 - 80 years, n=270) living in 21 
counties in Sweden.  They found that median (5th -95th percentile, ng/mL) serum concentration of 
PFHxS, PFOS, PFOA, and PFNA among the participants was 1.95 (0.73 - 10.29), 11.20 (3.89 - 
25.41), 2.25 (0.76 - 5.01), 0.80 (0.35 – 1.66), respectively (Bjermo et al., 2013). They found that 
higher education was significantly associated with higher concentrations of PFHxS (p = 0.02) 
and PFOS (p = 0.004), but not of PFOA (p= 0.009).  They also found that serum concentrations 
of the PFCs were higher among men than women after adjustments for age and education. 
However, after including total full breastfeeding time as a covariate in the regression analysis, no 
sex difference remained except for PFOS. They found significant regional differences in serum 
concentrations of all PFCs, except for PFNA, after adjusting for age, sex, and education level. 
Stockholm/Uppsala areas had twofold higher median concentrations of PFHxS as compared to 
Umeå, and Lund had 60 - 70% higher concentrations of median PFOS and PFOA as compared to 
Umeå. They indicated that the higher median concentrations of PFHxS in the 
Stockholm/Uppsala areas may have been due to the contamination of the communities’ water 
sources with PFHxS (Bjermo et al., 2013). 
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Brantsæter et al., (2013) examined factors associated with serum concentrations of PFOA, PFOS,  
PFHxS, and PFNA in pregnant women (n = 485) in Norway. The median (IQR) plasma level (in 
ng/ml) was 12.8 (10.1–16.6 ng/ml) for PFOS; 2.11 (1.54–2.93) for PFOA; 0.60 (0.43–0.86) for 
PFHxS; and 0.39 (0.28–0.51) for PFNA (Brantsaeter et al., 2013).  They also found parous 
women had 46%, 70%, 19%, and 62% lower concentrations of PFOS, PFOA, PFHxS, and 
PFNA, respectively when compared to nulliparous women. Additionally, increasing duration of 
breastfeeding, as well as increasing time since last pregnancy, was associated with decreasing 
levels of all PFCs (Brantsaeter et al., 2013). Zhou et al., (2014) performed a comprehensive 
exposure assessment of several PFCS in fishery employees from Tangxun Lake, located in Hubei 
Province, China which is the site of several small-scale fluorochemical manufacturers and users 
in China. They collected blood and urine samples from fishery employees (n =39; male = 38), 
their family members (n=7, male=1) and a background-exposed reference group (n=9, male=5). 
They found that levels of all PFCs in the fishery employees and their family members was 
significantly higher (2 to 3 orders of magnitude) than that of the reference group.  The median 
(ng/mL) blood serum concentrations of PFCs in fishery employees/family members/reference 
group were10400/3540/18.7 for PFOS, and 542/150/1.22 for PFHxS, and 41/11.7/2.88 ng/mL 
for PFOA, respectively.  They observed that increasing time of employment at the fishery was 
associated with an increase in serum PFC. After examining various exposure pathways, they 
concluded that contaminated fish from Tangxun Lake was the primary source of PFAS exposure 
to fishery employees (Zhou et al., 2014). 
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Geographical Location as a Health Determinant 
Generally speaking, an individual’s residence history is an important predictor of his/her current 
health status (Boscoe, 2011). Two factors which influence the association between residence 
history and current health status are socioeconomic factors, and the physical environment. 
Socioeconomic factors such as income, employment, and education, have a direct impact on the 
prevalence of chronic and psychosocial conditions ranging from heart disease, stroke, diabetes 
and cancer to obesity, depression, and teenage pregnancy (Jelleyman & Spencer, 2008; Power et 
al., 2005). The physical environment determines specific chemical exposures from air, soil, or 
water and can contribute to diseases such cancer, and birth defects. Most of the time, the quality 
of the socioeconomic environment and the physical environment are correlated (Boscoe, 2011).  
Research participants’ residential history is commonly used in studies that estimate lifetime 
exposure to environmental chemicals that have varying levels of exposure due to geographic 
location and other community-level characteristics (Boscoe, 2011; Ryan, Brokamp, Fan, & Rao, 
2015).  This becomes even more relevant in longitudinal studies where participants can change 
their residence during the course of the study. However, studies also indicate that residential 
mobility can be a source of exposure misclassification, since other factors such as indoor 
sources, and personal activities can affect exposure (Boscoe, 2011; Ryan et al., 2015; Van 
Ryswyk et al., 2014).  While some studies found that the inclusion of residential mobility as a 
factor increased the strength of association between health outcomes and environmental 
pollutants (Andersen et al., 2012; Gan et al., 2010), others found little or no change after 
inclusion of address history in their analysis (Canfield, Ramadhani, Langlois, & Waller, 2006; 
Chen, Bell, Caton, Druschel, & Lin, 2010). In urban areas, a relatively minor change in distance 
from one residence to the next can be associated with substantial changes in exposure levels 
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depending on proximity to the source of exposure, or terrain (Heckel & LeMasters, 2011).   
Therefore, studies that seek to examine the effect of environmental chemicals among large 
populations, such as general population sample of U.S. residents, can use geographic location as 
a proxy for exposure. 
Several studies have examined the association between residential history and various health 
outcomes. Several studies have been conducted in the Cape Cod region of Massachusetts, U.S.A. 
due to concerns about elevated cancer incidence in the region which may have been associated 
with air and water pollution from the Massachusetts Military Reservation (MMR), pesticide 
applications to cranberry bogs, particulate air pollution from a large electric power plant, and 
tetrachloroethylene-contaminated drinking water from vinyl-lined asbestos cement distribution 
pipes (McKelvey, Brody, Aschengrau, & Swartz, 2004; V. Vieira, Webster, Weinberg, & 
Aschengrau, 2009; V. M. Vieira, Webster, Weinberg, & Aschengrau, 2008). In various studies, 
increasing duration of residence was associated with an increased risk for breast cancer in the 
region (Brody et al., 2004; McKelvey et al., 2004).  McKelvey et al., (2004) found that breast 
cancer risk was elevated among women who had lived on Cape Cod for 5 or more years with a 
peak occurring in the 25 to less than 30-year category (AOR= 1.72; 95% CL, 1.12, 2.64) 
(McKelvey et al., 2004).  
Vieira et al., (2005, 2008, 2009) in a series of case-control studies using spatial-temporal 
analysis, evaluated the association between residential location and breast, lung and colorectal, 
bladder, kidney, and pancreatic cancer in the Upper Cod region using data from population-
based cancer registries.  Their cases and controls were selected from residents of that region with 
complete residential histories. They found evidence for spatial clustering of breast cancer (2005) 
in the region, and evidence of spatial and temporal elevated risk for breast (2008), kidney, and 
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bladder (2009) cancer. For instance, a large area of residence near the MMR and increased 
duration of residence was associated with a statistically significant elevated risk for breast cancer 
near the MMR (V. M. Vieira et al., 2008). 
In another study, Ziegler et al., (1993) examined the association between migration and breast 
cancer risk in Asian-American women. They found that risk for breast cancer was 60% higher 
among Asian-American women born in the West than those born in the East. Also, Asian-
American women with three or four grandparents born in the West had a 50% higher risk for 
cancer than those with all grandparents born in the East. Among the Asian-American women 
born in the East, those who had lived for a decade or longer in the United States had an 80% 
higher risk than more recent migrants, and those who lived in urban areas had a 30% higher risk 
than migrants from rural areas (Ziegler et al., 1993).    
Length of Residence as a Health Determinant 
In numerous studies among immigrants, length of residence in the United States has been shown 
to be associated with adverse health outcomes such as cardiovascular disease and other 
metabolic diseases (Kershaw et al., 2016; Koya & Egede, 2007; Salinas, Abdelbary, Rentfro, 
Fisher-Hoch, & McCormick, 2014). Salinas et al., (2014) examined the association between 
immigrant status, length of residence in the United States, age, and CVD markers in a cohort of 
Mexican American adults living in Brownsville, Texas. They found that long-term immigrants 
were significantly more likely to report having high cholesterol (OR=1.9, p=0.004), and had on 
average lower diastolic blood pressure (beta=-1.40, p=0.04) than short-term immigrants to. Also, 
U.S. born participants had on average significantly higher systolic blood pressure (beta=3.45, 
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p=0.003), lower average levels of total cholesterol (beta=-4.19, p=0.03), and average LDL 
cholesterol (beta=-3.77, p=0.03) than short-term immigrants.  
Kershaw et al., (2016) on the other hand examined the association between nativity and length of 
residence in the US, a commonly used proxy for acculturation, with indicators of low 
cardiovascular disease risk (not currently smoking; no diabetes; untreated total cholesterol 
<200mg/dL; untreated blood pressure <120/<80; body mass index <25 kg/m2; and no major 
ECG abnormalities) among a sample of Hispanics/Latinos resident in the United States. They 
found that women living in the US for less than 10 years had a lower risk for CVD than US-born 
women after adjusting for sociodemographic characteristics, diet, physical activity, and self-
reported experiences of ethnic discrimination (OR=1.96, 95% CI= 1.37, 2.80). However, length 
of residence was largely unrelated to CVD risk in Hispanic men.   
In another study, Koya & Egede (2007) examined the association between length of residence 
and cardiovascular disease risk factors among a national sample of U.S. immigrants.  They found 
that compared to those who had been resident in the U.S. for <10 years, those had been resident 
for ≥15 years were more likely to be obese (OR 1.31, 95% CI 1.03–1.65), have hyperlipidemia 
(OR 1.59, 95% CI 1.14–2.22), and be smokers (OR 1.39, 95% CI 1.04–1.85), but were less likely 
to live a sedentary lifestyle (OR 0.63, 95% CI 0.47– 0.84). They also found no association 
between length of residence and being diagnosed with diabetes or hypertension.  
Environmental Chemical Mixtures   
Several studies have demonstrated that children and adults are exposed to background 
concentrations of various environmental chemical mixtures  and that there is the possibility of 
synergism between low doses of mixtures of chemicals, which may result in different toxic 
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effects than that attributed to the individual chemicals  (Carpenter, Arcaro, & Spink, 2002; Claus 
Henn, Coull, & Wright, 2014; Hertzberg & Teuschler, 2002).   However, little is known about 
any adverse health outcomes associated with exposure to complex mixtures (Claus Henn et al., 
2014; Rappazzo et al., 2017). An analysis of the effect of exposure to these complex chemicals 
instead of one chemical at a time can help to accurately predict adverse health outcomes and 
design appropriate health interventions. In studies that have examined chemical mixtures, 
various statistical techniques such as principal component analysis, global scores, Bayesian 
model averaging, Hierarchical regression etc. have been used to generate summary variables 
from the multiple individual pollutants (Billionnet, Gay, Kirchner, Leynaert, & Annesi-Maesano, 
2011; Taylor et al., 2016). 
Some studies have examined the effects of exposure to environmental chemical mixtures on 
renal and liver metabolism and function. Tsai et al., (2017) examined the association between 
exposure to chromium, lead, and cadmium and renal function in a sample of 360 Taiwanese 
adults aged 18 years and older. They found that a doubling of urinary chromium or lead serum 
concentrations was associated with a 6.61 mL/min/1.73 m2 (95% CI= -9.71, -3.51) decrease in 
eGFR after adjusting for age, sex, body mass index, hypertension, diabetes, cigarette smoking, 
sodium intake, education, urinary volume, and other metals. Also, for participants in the highest 
tertile of cadmium exposure, eGFR decreased by 12.68 mL/min/1.73 m2 (95% CI= -20.44, -4.93) 
and 11.22 mL/min/1.73 m2 (95% CI= -17.01, -5.44), as urinary chromium or lead levels doubled, 
respectively. They concluded that there was a significant and independent association between 
chromium exposure and decreased renal function., and that co-exposure to lead and cadmium 
was potentially associated with additional decline in glomerular filtration rate in their sample 
(Tsai et al., 2017). 
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Chang et al., (2013) examined the association between mixed exposure to lead and organic 
solvents and liver function indicators among 593 occupationally-exposed male workers. They 
divided the sample into five groups: a lead-exposed group, an organic solvent-exposed group 
exposed to trichloroethylene (TCE co-exposed solvent group), an organic solvent-exposed group 
not exposed to trichloroethylene (TCE non-exposed solvent group), a lead and organic solvent-
exposed group (mixed exposure group), and a non-exposed group (control group). They 
compared geometric means of liver function indices among the groups and found that mean ALT 
and aspartate aminotransferase (AST) concentrations were higher in the mixed group, when 
compared to the other exposure groups.  After using general linear modeling (GLM) to control 
for the effect of age, work duration, BMI, smoking, and alcohol intake, the same results were 
obtained except for no significant difference in ALT levels between mixed exposure group and 
the TCE co-exposed solvent group (W. J. Chang, Joe, Park, Jeong, & Lee, 2013). 
Other studies have examined the effect of air pollution mixtures on respiratory outcomes. Arif et 
al., (2007) examined the association between exposure to volatile organic compounds (VOCs) 
and physician-diagnosed asthma among a cross-section of U.S. adults. They used exploratory 
factor analysis to group the VOCs into factors which were included as indicator variables. Based 
on a loading value greater than 0.4, they selected two factors represented by ‘‘aromatic 
compounds’’ and ‘‘chlorinated hydrocarbons’’. They found that the odds of physician-diagnosed 
asthma were significantly higher among those exposed to aromatic compounds when compared 
to those who are not exposed (aOR = 1.63, 95% CI: 1.17–2.27). Among those who did not have 
physician-diagnosed asthma, there was significantly increased odds of one to two wheezing 
attacks for exposure to aromatic compounds (aOR = 1.68, 95% CI: 1.08–2.61)., and chlorinated 
hydrocarbons (aOR = 1.50, 95% CI: 1.01–2.23) (Arif & Shah, 2007).  
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Qian et al., (2004) examined the association between multiple pathways of exposure to pollution 
from household coal combustion and environmental tobacco smoke (ETS), and respiratory 
health, using factor analysis, among a cross-section of 7058 children in China. They identified 
five factors: heating coal smoke, cooking coal smoke, socioeconomic status, ventilation, and 
environmental tobacco smoke (ETS) and parental asthma. They found that exposure to heating 
coal smoke was associated with increased odds of reporting cough with phlegm (OR= 1.29, 95% 
CI= 1.11 – 1.50), wheeze (OR= 1.22, 95% CI=1.02–1.45), and asthma (OR= 1.52, 95% 
CI=1.06–2.15). Cooking coal smoke was not associated with any of the outcomes. The odds of 
reporting a persistent cough and bronchitis was lower among individuals in lower socioeconomic 
groups. Also, increase in household ventilation was associated with a decrease in reports of 
persistent cough, persistent phlegm, cough with phlegm, bronchitis, and wheeze. Finally, they 
found that increasing exposure to ETS and the presence of parental asthma were associated with 
increased odds of reporting persistent cough, persistent phlegm, cough with phlegm, bronchitis, 
wheeze, and asthma (Qian, Zhang, Korn, Wei, & Chapman, 2004).  
Sherriff et al., (2005) examined the association between prenatal exposure to multiple chemical 
agents and the onset of wheezing in young children. They derived a score, called Total chemical 
burden (TCB), that was sum of the scores assigned to frequency of use of 15 different chemical-
based products, such as disinfectant, bleach, carpet cleaner, window cleaner, and dry cleaner 
fluid. They found increased odds of persistent wheezing during early childhood for participants 
with the top decile of TCB scores when compared to those in bottom decile scores (OR= 2.30, 
95% CI=1.20–4.39) but no significant associations were found with transient early wheeze or 
late-onset wheeze (Sherriff, Farrow, Golding, & Henderson, 2005). 
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Billionnet et al., (2011) examined the individual and combined effects of exposures to twenty 
VOCs on asthma and rhinitis on among a representative sample of the adult French population. 
They measured the concentrations of the VOCs in the indoor environments of 567 households. 
Also, 1012 eligible individuals living in 490 households completed a health questionnaire that 
measured their respiratory health.  Each VOC was categorized as a 0 if less than the 3rd quartile 
value, and 1 if greater. To account for the multi-exposure to pollutants and correlations between 
the VOCs, they generated a global score that represented the sum of the categorized VOCs, such 
that the global score is the number of air pollutants in the indoor environment with elevated 
concentrations (> 3rd quartile). They then used generalized estimating equation (GEE) to 
examine the association between various health indicators and each VOC and global VOC score. 
They found that increasing global VOC score was associated with increased odds of diagnosis of 
asthma in the past year (aOR=1.07; 95% CI= 1.00–1.13) and rhinitis (aOR=1.04; 95% CI= 1.00–
1.08). Significant positive associations were also found between aromatic and aliphatic 
hydrocarbons and asthma (aOR=1.12, 95% CI= 1.01–1.24; and aOR=1.41, 95% CI=1.03–1.93, 
respectively). Finally, they found significant positive associations between halogenated 
hydrocarbons and rhinitis (aOR 1.28; 95% CI= 1.07–1.54) (Billionnet et al., 2011).  
In another study, Qian et al., (2007) examined the association between diverse sources of 
household combustion pollution sources and respiratory health among a sample of 2360 Chinese 
fathers and 463 children.  They hypothesized that exposure to the pollution sources and their 
factors was positively associated with the prevalence of respiratory conditions in the men, and 
negatively associated with the children’s lung function, as measured by forced vital capacity 
(FVC), and forced expiratory volume at 1s (FEV1). Using a factor analysis, they generated five 
different uncorrelated factors among the men (Heating coal smoke, Cooking coal smoke, 
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Ventilation, Socioeconomic status, and Any home cigarette smoker) and three different factors 
among the children (Cooking coal smoke, Heating coal smoke, and Ventilation). Among the 
adults, they found that heating coal smoke was associated with an increased prevalence of 
persistent cough, persistent phlegm, and wheeze; and cooking coal smoke was associated with 
increased prevalence of physician-diagnosed of asthma. They also observed decreasing 
pulmonary function with increase in exposure to cooking coal smoke among the children (Qian 
et al., 2007).  
Studies that have examined the effects of multiple PFCs found that the associations between an 
individual PFC and a health outcome is usually complicated by correlations among the different 
PFCs, and similar associations between the health outcome and some of the multiple PFCs 
(Grandjean et al., 2012; Granum et al., 2013; Stein et al., 2016), which complicates the 
conclusions of these studies.   However, available studies have yet to address the combined 
effect of exposure to multiple PFCs and any adverse health outcomes.   
The Foreign-born U.S. Population 
The U.S. Census Bureau describes foreign-born U.S. residents as individuals who are not U.S. 
citizens at birth; as compared to native-born residents who are born in the United States, Puerto 
Rico, or a U.S. Island area, or are born abroad to at least one U.S. citizen parent (Grieco et al., 
2012). Nearly 53 percent of the foreign-born were born in Latin America, 28 percent in Asia, 12 
percent in Europe, 4 percent in Africa, 2 percent in Northern America, and less than 1 percent in 
Oceania. Individuals born in Mexico are the largest foreign-born population, comprising 55 
percent (11.7 million) of Latin American-, and 29 percent of the total foreign-born population 
(Grieco et al., 2012). 
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Immigrant populations often tend to have increased risk for inadequate access to health care due 
to political and social marginalization (Derose, Escarce, & Lurie, 2007). However, despite these 
disparities, they tend to have better health and lower mortality rates (Singh & Miller, 2004; 
Singh & Siahpush, 2002). This has been referred to as the immigrant health paradox (Scribner, 
1996; Speciale & Regidor, 2011). This may be because migration is selective of healthier 
individuals (Marmot, Adelstein, & Bulusu, 1984; Norman, Boyle, & Rees, 2005), and 
immigrants are less likely to engage in risky behaviors and more likely to engage in healthy 
behaviors (Borrell, Castor, Conway, & Terry, 2006; Scribner, 1996). However, with increasing 
length of stay in the U.S., immigrants are more likely to adopt U.S. norms and behaviors which 
may nullify their health advantages and lead to a decline in health status (Abraido-Lanza, Chao, 
& Florez, 2005). Most studies have examined the association between increasing length of 
residence in the U.S. and increased odds of obesity, chronic conditions and other cardiovascular 
risk factors among immigrants (Goel, McCarthy, Phillips, & Wee, 2004; Kaplan, Huguet, 
Newsom, & McFarland, 2004; Koya & Egede, 2007). It is unknown whether any studies have 
examined the association between length of residence and blood serum concentrations of PFCs. 
Summary 
PFCs are widely occurring environmental chemicals that are persistent, bioaccumulative and 
toxic to both animals and humans. Numerous studies have shown differences in exposure to 
background concentrations of these chemicals among populations in several countries 
worldwide. PFCs are associated with adverse health outcomes including renal and liver 
dysfunction. However, no studies have established exposure limits for background 
concentrations of PFCs in the environment. The development of such exposure limits will be 
dependent on biomonitoring studies among populations over a period of time. Foreign-born U.S. 
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residents are potentially a population that may have historically low exposure concentrations to 
PFCs when compared to native-born U.S. residents.  They therefore present a unique population 
to determine if increasing length of residence in the U.S. will be associated with increasing 
serum concentrations of selected PFCs. If there is a significant increase in the serum 
concentrations, then further analysis can be performed to determine if the association between 
the selected PFCs and renal and liver function indicators will be different among this population 
when stratified by length of years of residence.  
Additionally, even though PFCs occur as mixtures of multiple chemicals in the environment and 
blood and serum samples, the health effects of the complex mixtures are largely unknown 
(Rappazzo et al., 2017). Further analysis will be carried out to determine the combined effects of 
exposure to the selected PFCs and renal and liver function indicators. Finding from this study 
can help inform future designs of more rigorous studies, such as longitudinal studies, among this 
population.   
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Chapter III: Methods 
Data Source 
Data from the 2007 – 2012 waves of the US National Health and Nutritional Examination 
Survey (NHANES) were used for this study. The NHANES is a stratified multistage probability 
sample of the Civilian non-institutionalized U.S. population (Centers for Disease Control, 2010). 
For each survey year, a random 1/3 subsample of participants 12 years or older were selected for 
the measurement of blood serum PFC concentrations  (Centers for Disease Control, 2010). 
Multiple waves of NHANES data were selected and used for this study to increase the study 
sample size. PFCs selected for this study were PFOA, PFOS, PFHxS, and PFNA because they 
are the ones most often included in most epidemiological studies. Similar to other studies that 
have been conducted among the NHANES subsample (Taylor, Hoffman, Thayer, & Daniels, 
2014; Webster et al., 2016), only 20 years and older participants assayed for the selected PFCs 
were eligible for this study.  A complete description of the NHANES survey methodology is 
described elsewhere (National Center for Health Statistics, 2018). 
Independent Variables 
The main independent variables of interest were the PFCs (PFOA, PFOS, PFHxS and 
PFNA), place of birth, and length of residence in the U.S. (Categorized as <10, 10 – 19, and 20+ 
years).  The PFC concentrations were natural-log transformed to approximate normal 
distributions before statistical analysis. Mean (SE), median, and quartile values were used to 
describe serum PFC concentrations. 
Covariates: Potential covariates were selected a priori based on evidence from other studies 
(Gleason et al., 2015; Lin et al., 2009; Steenland et al., 2009). These covariates include age, sex, 
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race/ethnicity, body mass index (BMI), smoking status, heavy alcohol use, level of education, 
and impaired glucose tolerance and hypertension. Individuals were classified as smokers if they 
had serum cotinine levels > 1.78 ng/mL for men and > 4.47 ng/mL for women (Benowitz, 
Bernert, Caraballo, Holiday, & Wang, 2009; Caraballo, Giovino, Pechacek, & Mowery, 2001). 
BMI was calculated as weight in kilograms divided by height in meters squared (National Heart 
Lung and Blood Institute, 1998). Heavy alcohol use was defined as consumption of 5 or more 
drinks on at least one day over the past 12months (Ward, Clarke, Nugent, & Schiller, 2016).  
Impaired glucose tolerance was defined as having a fasting blood glucose level greater than or 
equal to 100mg/dl, or currently on prescribed medication to lower blood sugar (American 
Diabetes Association, 2014). Hypertension was defined as currently taking prescribed 
medication for high blood pressure or having a systolic blood pressure at 140mmHg or higher, or 
a diastolic blood pressure at 90 mmHg or higher (American Heart Association, 2018). 
Outcome Variables 
Renal Function: Serum creatinine measurements obtained in the NHANES were used to 
measure kidney function. Estimated glomerular filtration rate (eGFR; measured in 
mL/min/1.73m2) was calculated from serum creatinine values by using the 4-variable 
Modification of Diet in Renal Disease study equation: eGFR=175 * (serum creatinine in mg/dL)-
1.1543 * (age in years)-0.2033 *(0.742 if female)*(1.21 if black) (Levey et al., 2006). The eGFR 
values were then categorized based on the National Kidney Foundation cut-off values for CKD:  
GFR ≥ 90 (Normal) and GFR<90 (Low) (National Kidney Foundation, 2002). Weighted means 
with 95% confident intervals (CIs) were calculated for eGFR values. 
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Liver Function: Three markers of liver injury available from the NHANES were used 
for this study: alanine aminotransferase (ALT), γ-glutamyltransferase (GGT) and Total bilirubin. 
Total bilirubin is mostly derived from the metabolism of hemoglobin and increases are usually 
indicative of dysfunction of the liver, bile ducts, or gall bladder. ALT is present in liver 
parenchymal cells and is elevated during acute liver damage. Elevation of GGT levels is an early 
sign of cholestatic disorders, where flow of bile from the liver is slowed or impeded (Rosalki & 
Mcintyre, 1999).  Each biomarker of liver function was dichotomized by creating threshold 
values for high concentrations using cut-off values from previously published studies: 45 IU/L in 
males and 34 IU/L in females for ALT (Schumann et al., 2002a), 55 IU/L in males and 38 IU/L 
in females for GGT (Schumann et al., 2002b), and 0.3 mg/dL in both sexes for total bilirubin 
(McPherson & Pincus, 2017). The cutoff values reflect the reference ranges beyond which the 
concentrations of the liver function indicators would be considered abnormally high and could 
prompt additional investigation in a clinical setting (Darrow et al., 2016). The continuous 
measures of liver biomarkers were natural log-transformed and their weighted means with 95% 
confident intervals (CIs) were calculated. 
Statistical Analysis:  
Research Question 1 and 2: Demographic characteristics of the study sample were 
described using frequencies. Multiple linear regression analysis was used to calculate the least 
square geometric means (LSGM) of the log-transformed PFC concentrations by place of birth, 
and length of residence, controlling for gender, race, age, educational level, and smoking status. 
Similarly, multiple regression was used to calculate the Least Square Means (LSM) of eGFR by 
place of birth, and by length of residence, controlling for education level, smoking status, heavy 
alcohol use, impaired glucose tolerance, and hypertension diagnosis. Gender, age and race were 
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not included in calculating differences in LSM of eGFR because their impact on eGFR had 
already been accounted for in the Modification of Diet in Renal Disease study equation (Levey et 
al., 2006) . 
Research Question 3a. & 3b: In assessing the associations between individual PFCs and 
eGFR, multivariable logistic regression models were used to estimate the odds of having low 
eGFR for every unit increase in log-PFC serum concentrations. In Model 1, the crude association 
between serum PFCs and eGFR were determined, and in Model 2 the association was 
determined controlling for smoking status, BMI, heavy alcohol use, impaired glucose tolerance, 
hypertension status, total cholesterol level, and education level.  The regression analyses were 
carried out both for the overall sample of foreign-born residents, and then stratified by length of 
residence to examine any significant differences by length of residence. 
Research Question 4a. & 4b: Multiple linear regression was used to calculate the Least 
Square Means (LSM) of liver function biomarkers by place of birth, and by length of residence, 
controlling for race/ethnicity, educational level, smoking status, heavy alcohol use, impaired 
glucose tolerance, and hypertension diagnosis. Logistic regression models were used to 
determine the odds of having elevated ALT, GGT, or total bilirubin for every unit increase in 
log-PFC serum concentrations. In Model 1, the crude association between serum PFCs and the 
liver function biomarkers were determined, and in Model 2 the association was determined 
controlling for race, age, smoking status, BMI, heavy alcohol use, impaired glucose tolerance, 
hypertension status, total cholesterol level, and education level. The regression analyses were 
carried out both for the overall sample of foreign-born residents, and then stratified by length of 
residence to examine any significant differences by length of residence. 
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Research Question 5:  Correlation analysis was used to examine the association between 
individual PFCs and the outcome variables. Principal component analysis (PCA) was then used 
to generate linear combinations of the PFC serum concentrations using the SAS software 
principal components procedure (version 9.4; SAS Institute, Inc, Cary, NC). Principal 
components with observed eigenvalues greater than 1.0 were further evaluated. The larger the 
absolute value of a loading for a variable to a principal component, the greater the contribution 
of that variable to that principal component. Variables that had loadings of 0.40 or greater were 
considered as making a reasonable contribution to the principal component. In PCA, the second 
principal component is independent of the first principal component and the third is independent 
of the first two principal components (Hu et al., 2018; Navarro Silvera et al., 2011). Therefore, 
labeling of the principal components was done based upon interpretation of the data. 
After a varimax rotation, which typically makes the principal component more 
interpretable, principal component scores were generated using the SAS Proc Factor command 
(O’Rourke & Hatcher, 2013). These scores represent the weighted sums of the exposure 
variables, where the weights are equal to the principal component loading (O’Rourke & Hatcher, 
2013). The scores were then categorized into quartiles and multivariate unconditional logistic 
regression analyses was used to examine the association between the component scores and the 
dichotomized eGFR, and liver function biomarkers by calculating odds ratios (OR) and 
corresponding 95% confidence intervals (CI). In model 1, the association between a principal 
component and eGFR, ALT, GGT, and total bilirubin was mutually adjusted for all other 
principal components from the factor-loading matrix. In model 2, all other covariates of interest 
were additionally included. All tests of significance were two-sided, with a pvalue of 0.05 
considered statistically significant. 
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Chapter IV: Results 
 
Demographic Characteristics of Study Sample: The demographic characteristics of the study 
participants are outlined in Table 1. The general sample consisted of 5167 adults aged 20 or 
more years (3678 native and 1485 foreign-born). Males comprised 2521 (48.1%) of the general 
sample, 1786 (47.7%) of the native-born and 732 (49.6%) of the foreign-born participants.  
Approximately 69% of general sample were non-Hispanic white, 10% were non-Hispanic black, 
8% were Mexican American and 13% were ‘Other’ race. Most the participants were aged 
between 20 – 39 years (36.5%) or 40 – 59 years (39.4%).  Among the foreign-born residents, 384 
(33.6%), 373 (26.8), and 661 (39.7) had been U.S. residents for <10 years, 10 – 19 and 20+ 
years, respectively.  
Associations between PFCs and Renal Function: Foreign-born residents had lower mean and 
median concentrations for all the examined PFCs when compared to native-born residents (Table 
2). The median (ng/ml) PFOA, PFOS, PFHxS, and PFNA serum concentrations of native and 
foreign-born residents were respectively; PFOA (3.35 vs. 2.46), PFOS (10.29 vs. 8.19), PFHxS 
(2.53 vs. 1.81), and PFNA (1.43 vs. 1.40).  Similarly, among the foreign-born residents, mean 
and median concentrations of all the PFCs increased as length of residence in the U.S. increased. 
The mean serum concentrations (ng/ml) of PFCs for foreign-born individuals who had been 
resident in the US for 10, 11-19 and 20 or more years were respectively 2.64, 2.84 and 3.46 for 
PFOA; 2.64, 2.84 and 3.46 for PFOS; 1.15, 1.59 and 2.52 for PFHxS; and 1.25, 1.45 and 1.47 for 
PFNA (Table 2).  The log-transformed PFCs were moderately to strongly positively correlated 
(Range, r = 0.47 – 0.70) (Table 3).   
The least square geometric mean (LSGM) concentrations of PFCs were compared by 
place of birth and length of residence. As shown in Table 4, adjusted LSGM concentrations of 
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PFOA and PFHxS were significantly higher among native-born than foreign-born residents (p 
<.05). Among foreign-born residents, adjusted LSGM concentrations of PFOS and PFHxS were 
significantly higher among individuals who were resident in the U.S. for 20+ years when 
compared to those resident for <10 years; and adjusted LSGM concentrations of PFHxS among 
those resident for 10– 19years was significantly higher than among those resident for <10 years.  
There were no statistically significant differences in PFOA and PFNA concentrations by length 
of residence in the U.S. (Table 4). 
Mean eGFR was higher among the foreign-born participants when compared to native-
born participants. However, mean eGFR decreased as the length of years of residence among 
foreign-born participants increased (Table 5).  After adjusting for educational level, smoking 
status, heavy alcohol use, impaired glucose tolerance, and hypertension diagnosis, LSM of eGFR 
was significantly higher among foreign-born residents when compared to native-born residents 
(p<0.001). Similarly, LSM of eGFR among foreign-born residents who had been resident for 
<10 years was significantly higher than the LSM eGFR among those who had been resident for 
20+ years (p=0.002).  There was no significant difference in eGFR between foreign-born 
individuals who had been resident for <10 years vs. 10-19 years and 10-19 vs. 20+ years (Table 
5).    
Results showing the odds of low eGFR with increasing serum concentrations of PFCs are 
presented in Table 6.  After adjusting for all covariates, a unit increase in logPFOA serum 
concentrations was associated with a twofold increased odd of having low eGFR (OR=2.04; 95% 
CI=1.26 – 3.28), a unit increase in logPFHxS serum concentrations was associated with a 40% 
increased odds of having low eGFR (OR=1.40; 95% CI =1.09 – 1.79), and a unit increase in 
logPFOS serum concentrations was associated with an 88% increased odds of having low eGFR 
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(OR=1.88; 95% CI =1.48 – 2.39). On stratifying by length of residence, logPFOA serum 
concentrations were significantly associated with low eGFR among individuals who had been 
resident for 10-19 years (OR=2.96; 95% CI=1.37 – 6.39), and 20+ years (OR=3.59; 95% 
CI=1.45 – 8.90), logPFHxS serum concentrations were significantly associated with low eGFR 
among individuals who had been resident for 20+ years (OR=2.38; 95% CI=1.53 – 3.70), and 
logPFNA serum concentrations were significantly associated with low eGFR among individuals 
who had been resident for 10–19 years (OR=6.04; 95% CI=2.59 – 14.11). Except for logPFNA, 
there was an increasing trend in the odds ratio estimates with increase in length of residence, 
though not all the associations were significant (Table 6). 
Association between PFCs and Liver Function Indicators: The mean ALT serum 
measurements among native-born and foreign-born residents were respectively 25.52 (IU/L) and 
26.78 (IU/L). After adjusting for age, race/ethnicity, educational level, smoking status, heavy 
alcohol use, impaired glucose tolerance, and hypertension diagnosis, least-square mean (LSM) 
ALT measurements were significantly higher among foreign-born residents when compared to 
native-born residents (31.12 vs. 28.24, p=0.02) (Table 7).  The mean serum concentrations 
(IU/L) of ALT for foreign-born individuals who had been resident in the US for 10, 11-19 and 20 
or more years were respectively 26.80, 28.06 and 25.76.  The LSM concentration of ALT were 
significantly higher among individuals who had been resident in the U.S. for 10-19 years when 
compared to that of those who had been resident for 20+ years (34.94 vs. 32.06, p=0.04). No 
significant differences in serum concentrations of GGT were observed among native-born and 
foreign-born individuals. However, LSM of GGT among foreign-born residents who had been 
resident for 10-19 years (42.75) was significantly higher than that among both those who had 
been resident for <10 years (36.48, p=0.01), and 20+ years (37.50, p=0.003) (Table 8).  Mean 
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total bilirubin measurements among native-born and foreign-born residents were respectively 
0.76 and 0.74 mg/dl. LSM of total bilirubin concentrations were significantly higher among 
native-born than foreign-born residents (0.75 vs. 0.72 mg/dl, p=0.03).  There was no significant 
difference in total bilirubin measurements by length of years of residence among foreign-born 
individuals (Table 9).    
The odds of elevated liver function biomarkers with increasing serum concentrations of 
PFCs are presented in Tables 10-12.  There were no significant associations between the selected 
PFCs and ALT in the total sample of foreign-born residents. On stratifying by length of 
residence, significant associations were observed among individuals who had been resident for 
20 years or more. Among this subsample of foreign-born individuals, a unit increase in logPFOA 
serum concentrations was associated with a 49% increased odds of having elevated ALT 
(OR=1.49; 95% CI=1.00 – 2.22), a unit increase in logPFOS serum concentrations was 
associated with a 37% increased odds of having elevated ALT  (OR=1.37; 95% CI =1.02 – 1.82), 
and a unit increase in logPFHxS serum concentrations was associated with a 65% increased odds 
of having elevated ALT (OR=1.65; 95% CI =1.28 – 2.14) (Table 10).  After controlling for all 
covariates, there were no significant associations between the selected PFCs and GGT in the 
total sample but on stratifying by length of residence, individuals who had been resident for 20+ 
years had a 98% increased odds of having elevated GGT for a unit increase in logPFOA serum 
concentrations (OR=1.98; 95% CI =1.07 – 3.69) (Table 11).   
After controlling for all covariates in the total sample of foreign-born residents, a unit increase in 
logPFOS serum concentrations was associated with a 69% increased odds of having elevated 
total bilirubin (OR=1.69; 95% CI =1.12 – 2.53), a unit increase in logPFHxS serum 
concentrations was associated with a 60% increased odds of having elevated total bilirubin 
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(OR=1.60; 95% CI =1.11 – 2.30), and a unit increase in logPFNA serum concentrations was 
associated with an 81% increased odds of having elevated total bilirubin (OR=1.81; 95% CI 
=1.05 – 3.13) (Table 12). After stratifying by length of residence, logPFOS serum concentrations 
were significantly associated with elevated  total bilirubin among individuals who had been 
resident for 10-19 years (OR=2.31; 95% CI=1.13 – 4.72),  logPFHxS serum concentrations were 
significantly associated with elevated  total bilirubin among individuals who had been resident 
for 10-19 years (OR=2.01; 95% CI=1.08 – 3.72), and logPFNA serum concentrations were 
significantly associated with elevated  total bilirubin among individuals who had been resident 
for 10–19 years (OR=3.02; 95% CI=1.20 – 7.65) (Table 12). 
Association between Combined Exposure to PFCs and Renal and Liver Function: Principal 
component loadings for each of the PFCs are shown in Table 13. The principal axis method was 
used to extract the components, and this was followed by a varimax rotation. Three components 
were retained in the analysis, which together accounted for 94.9% of the total variance. In 
interpreting the rotated factor pattern, an item was said to load on a given component if the factor 
loading was .40 or greater for that component.   The first pattern loaded heavily on PFOS and 
PFHxS and was therefore termed PFOS/PFHxS pattern. In contrast, the second principal 
component, termed a PFOS/PFNA pattern, loaded heavily on PFOS and PFNA. The third 
principal component was distinguished from the others as it loaded most heavily on only PFOA.   
After controlling for principal components factors, smoking status, BMI, heavy alcohol use, 
impaired glucose tolerance, hypertension status, total cholesterol level, and education level, 
significant direct associations were found between increasing quartiles of the PFOS/PFHxS 
components and low eGFR (OR: Q2 vs. Q1= 1.38, 95% CI: 1.04 - 1.83; Q3 vs. Q1= 1.53, 95% 
CI: 1.16 - 2.01; Q4 vs. Q1= 2.41, 95% CI: 1.82 – 3.19) (Table 14). There was a significant 
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positive association between the PFOA principal component and ALT concentrations (OR: Q4 
vs. Q1= 1.28, 95% CI: 1.00 - 1.64), but the association was not significant after adjusting for 
covariates (Table 15).   None of the principal component factors were significantly associated 
with elevated GGT (Table 16).  There was a significant association between the PFOA principal 
component and elevated total bilirubin in the crude model (OR: Q4 vs. Q1= 1.80, 95% CI: 1.25 – 
2.58), but not in the adjusted model (Table 17).   After adjusting for all covariates, significant 
direct associations were found between elevated total bilirubin and increasing quartiles of the 
PFOS/PFHxS component (OR: Q2 vs. Q1= 2.33, 95% CI: 1.17 – 4.64; Q3 vs. Q1= 2.47, 95% 
CI: 1.24 – 4.92; Q4 vs. Q1= 2.82, 95% CI: 1.42 – 5.16) (Table 17). 
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Chapter V: Discussion, Conclusions and Recommendations 
Discussion 
Associations between PFCs and Renal Function: Results from this study showed that foreign-
born residents had lower mean and median concentrations for all the examined PFCs when 
compared to native-born residents. Among the foreign-born residents, mean and median 
concentrations of PFOS and PFHxS increased as length of residence in the U.S. increased. 
Additionally, among the foreign-born the serum concentrations of PFOS and PFHxS increase as 
the number of years of residence increase. Internal exposure to PFCs is usually measured based 
on concentrations in plasma, serum or whole blood (Fromme et al., 2009). Because PFCs, such 
as PFOS and PFOA, are very persistent chemicals that do not undergo metabolism, serum PFC 
concentrations are indicative of cumulative exposure overs several years (Yusa, Ye, & Calafat, 
2012), and body burdens may increase with increasing age (Fromme et al., 2009). Several studies 
have also shown that that serum concentrations, such as PFOA and PFOS, are higher in males 
than females (Calafat, Kuklenyik, et al., 2007; Fromme H. et al., 2007; Harada et al., 2004; 
Kärrman et al., 2006).  However, other studies did not find significant sex-related differences in 
PFOA and PFOS concentrations (Kannan et al., 2004; Olsen, Church, et al., 2003; Olsen, 
Hansen, et al., 2003). In our analyses, we controlled for age and sex when we examined the 
differences in PFC serum concentrations. Thus, the results suggest that foreign-born U.S 
residents have, on average, lower serum concentrations of PFCs when compared to native-born 
residents, and that the exposure concentrations increase with increasing years of residence in the 
U.S. among the foreign-born. Available studies have mostly demonstrated that serum 
concentrations of PFCs differed between samples taken in different countries (Fromme et al., 
2007; Fromme et al., 2009; Kannan et al., 2004), and not among various population subgroups in 
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the same country.  Several factors can be suggested as contributing to the observed differences in 
PFC serum concentrations. Mean and median concentrations of PFCs seem to be higher in North 
American populations than in European, Asian, and Australian populations, with most 
concentrations highest in U.S. samples (Fromme et al., 2009). Studies also show that average 
PFC concentrations in outdoor air tend to be higher in urban communities when compared to 
rural communities (Fromme et al., 2009; Jahnke, Ahrens, Ebinghaus, & Temme, 2007; Martin et 
al., 2002). Thus, exposure to PFCs is likely to be higher in more urbanized and industrialized 
societies than in rural societies. This is supported by  studies that show that urban populations 
have higher serum concentrations of PFCs than rural populations (Fu, Wang, Wang, Fu, & Lu, 
2014; Hanssen et al., 2010). Immigrants are also more likely to engage in high risk occupations, 
and live is socioeconomically deprived communities with an increased exposure to 
environmental chemicals (Eamranond & Hu, 2008). Subsequently, with time they may develop 
increased levels of environmental chemicals after arrival to the U.S (Eamranond & Hu, 2008).  
 Mean eGFR was higher among the foreign-born participants when compared to native-born 
participants, and eGFR was significantly higher among foreign-born residents who had been 
resident for <10 years when compared to those who had been resident for 20+ years. Except for 
logPFNA, there was an increasing trend in the odds ratio estimates with increase in length of 
residence, though not all the associations were significant. Studies have shown that increasing 
age is associated with decreasing kidney function (Denic, Glassock, & Rule, 2016; Weinstein & 
Anderson, 2010). Considering that increasing length of residence will be associated with 
increasing age, the inclusion of age in the eGFR estimates accounted for its effect. Other 
covariates that were included in the analysis were smoking and heavy alcohol use, as well as 
diagnosis of diabetes and hypertension. Other clinical conditions that may be associated with 
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increasing age and decreased renal function were not included in the analysis. Future studies can 
examine this relationship by including more potential covariates in the analysis 
After adjusting for all covariates, a unit increase in log-PFOA, log-PFHxS, and log-PFNA 
concentrations were associated with increased odds of having low eGFR. This finding is 
consistent with previous studies that found that increasing serum concentrations of both PFOA 
and PFOS were inversely associated with eGFR levels (Watkins, Josson et al., 2013), and 
positively associated with CKD (Shankar, Xiao et al., 2011). Watson et al., (2013), also found 
that increased serum PFNA levels were significantly associated with decreased eGFR.  
On stratifying by length of residence, logPFOA serum concentration was significantly associated 
with low eGFR among individuals who had been resident for 10-19 years, and 20+ years, 
logPFHxS serum concentration was significantly associated with low eGFR among individuals 
who had been resident for 20+ years, and logPFNA serum concentration was significantly 
associated with low eGFR among individuals who had been resident for 10–19 years. Previous 
studies show that length of residence is an important proxy for determining risk for some chronic 
diseases (Kershaw et al.,2016, Abraido-Lanza, Chao et al., 2005, Koya and Egede 2007, Voeks, 
McClure et al., 2008, Howard, Woolson et al., 2010). For example, among immigrants in the 
United States, longer duration of residence was found to be associated with increased odds of 
obesity and hyperlipidemia (Koya and Egede 2007).  Similarly, compared to other parts of the 
United States, lifetime residence in the Southeastern region of the U.S. is associated with a 
higher prevalence of diabetes (Voeks, McClure et al., 2008), and hypertension (Howard, 
Woolson et al., 2010); two important risk factors for kidney dysfunction.  The results suggest 
that increasing length of residence in the US, which can be an indicator for exposure to 
background concentrations of PFCs in the general population, may be associated with increasing 
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serum concentrations of some PFCs, and may mediate the association between the PFCs and 
renal function. Length of residence is therefore an important factor to consider in studies that 
examine the association between PFCs and associated health outcomes. 
Association between PFCs and Liver Function Indicators: The results showed that after 
adjusting for age, race/ethnicity, educational level, smoking status, heavy alcohol use, impaired 
glucose tolerance, and hypertension diagnosis, when comparing foreign-born and native-born 
U.S. residents, least-square mean (LSM) ALT measurements were significantly higher among 
foreign-born residents, no significant differences in serum concentrations of GGT were 
observed, and LSM of total bilirubin concentrations were significantly higher among native-born 
residents.  Among foreign-born residents LSM concentration of ALT were significantly higher 
among individuals who had been resident in the U.S. for 10-19 years when compared to that of 
those who had been resident for 20+ years, LSM of GGT of those who had been resident for 10-
19 years was significantly higher than those who had been resident for <10 years, and 20+ years, 
and there was no significant difference in total bilirubin measurements by length of years of 
residence.   Total bilirubin, ALT, and GGT are useful biomarkers of liver function, with an 
increase beyond certain thresholds classified as indicative of liver damage (Johnston, 1999). The 
results were inconclusive on whether differences in liver function biomarkers are significantly 
different between native- and foreign-born U.S. residents.  
Also, there were no significant associations between the selected PFCs and ALT in the total 
sample of foreign-born residents. Among individuals who had been resident for 20 years or 
more, a unit increase in logPFOA serum concentrations was associated with an increased odds of 
having elevated ALT, and elevated GGT; unit increases in logPFOS and logPFHxS serum 
concentrations were associated with an increased odds of having elevated ALT. On the other 
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hand, increases in logPFOS, logPFHxS, and logPFNA serum concentrations were associated 
with increased odds of having elevated total bilirubin in the total sample of foreign-born 
residents. After stratifying by length of residence, logPFOS, logPFHxS, and logPFNA serum 
concentrations were significantly associated with elevated total bilirubin among individuals who 
had been resident for 10-19 years. Available studies on the association between PFCs are 
inconclusive, with some suggesting that increasing concentrations of PFOA were associated with 
significant increase in total bilirubin (Costa et al., 2009; Olsen & Zobel, 2007; Sakr et al., 2007), 
while others observed a U-shaped exposure-response pattern (Gallo et al., 2012). Other studies 
have observed associations between PFOA and ALT, GGT, and hepatocellular damage (Darrow 
et al., 2015). The results suggest that some of the PFCs may have a significant association with 
the liver function indicators, even though the findings are not conclusive after stratifying by 
length of residence.  
The lack of significance in the associations between some PFCs and the liver function indicators 
could be due to a variety of reasons. Bilirubin is produced from the breakdown of hemoglobin 
within the reticuloendothelial system and can be elevated due to other factors such as over 
production of bilirubin, acute hepatitis, decreased hepatic uptake, viral hepatitis, or ischemic liver 
injury (Gowda et al., 2009). Also, the are studies that suggest that ALT and GGT can be elevated 
due to other nonspecific liver injuries, and may remain at normal levels in cases of chronic liver 
cell damage (Gowda et al., 2009). Future studies can examine the associations between PFCs and 
liver function using other indicators, or a summary index such as the Aspartate amino 
transferase: Alanine amino transferase (AST/ALT) ratio (Giannini et al., 2003; Gowda et al., 
2009).  
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Association between Combined Exposure to PFCs and Renal and Liver Function: After 
controlling for all covariates, increasing quartile concentration of the PFOS/PFHxS principal 
component was associated with increased odds of low eGFR, and elevated total bilirubin. Also, 
increasing quartiles of the PFOA principal component were associated with elevated ALT and 
elevated total bilirubin concentrations in the crude model. However, the relationship was not 
significant after adjusting for all covariates. There are currently no available studies on the 
effects of simultaneous exposure to multiple PFCs and adverse health outcomes. Nevertheless, 
the findings of this study suggest that PFOS and PFHxS may have additive/synergistic effects on 
renal and liver function. Future studies, such as longitudinal studies, can examine this effect. 
Limitations: This study is subject to a few limitations. The NHANES is a cross-sectional study, 
which does not eliminate the possibility of reverse causality.  Hence the significant associations 
between the selected PFCs and low eGFR observed may not indicate a causal relationship. It 
may be argued that the increasing serum PFC concentrations may in fact be causing or be the 
result of decreased kidney function or some combination of the two. A more robust study design, 
such as a longitudinal study with a larger sample size may be more effective at identifying 
significant associations between increasing PFC concentrations and risk of kidney or liver 
dysfunction.  
This study did not examine the age and sex distributions of the foreign-born and native-born 
residents. There may be the possibility of misclassification bias due to differences in the age and 
sex distributions between the two groups. Future studies can look at variation between these 
groups.  
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Another limitation is the designation of ‘Foreign-born’ respondents. While respondents can 
accurately indicate their place of birth, the question does not measure residential history. It is 
possible that the foreign-born residents live in more urban locations when compared to some 
native-born residents. Also, foreign-born residents may not have necessarily spent all their lives 
residing in their country of origin before moving to the U.S. Considering that residential history 
plays a significant role in level of exposure, participants’ historical exposures will have an 
important impact on their levels of exposure to PFCs.  Therefore, this is likely to introduce some 
measure of bias into the study since just one question is used to determine place of birth, and 
length of exposure is designated by length of residence in the US. However, the findings show 
that exposure levels may still be different based on length of residence among this representative 
sample of foreign-born and native-born U.S. residents. 
 Also, we are unable to identify the country of birth of respondents. Differences observed among 
foreign-born individuals based on length-of-residence may be impacted by participants’ exposure 
history from their country of birth. Future studies can examine differences in PFC serum 
concentrations among foreign-born individuals from specific countries. 
Also, past studies on the impact of PFCs on renal and liver function have mostly been carried out 
among occupationally exposed cohorts and in communities exposed to historically elevated 
levels. In such situations, it may be possible to elucidate the associations exposures to the high 
concentrations and adverse health outcomes.  Studies that focus on the effects of low dose 
background exposures to PFCs in the general population may not observe significant findings. 
Additionally, liver and renal dysfunction can occur due to the presence of many other factors 
such as heavy alcohol use, use of some medications, and some preexisting health issues. 
Therefore, if the general population is exposed to low dose concentrations of these chemicals, 
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liver and renal dysfunction can occur through the additive or interaction effects of these factors, 
some of which were not accounted for in the analysis. 
 This study operated on the premise that foreign-born US residents who were recent migrants 
were more likely to have lower exposures when compared to longer term foreign-born residents. 
Studies have shown that the health status of newly arrived immigrants can vary over a very short 
period, such as within 5 years (Jasso, Massey, Rosenzweig, & Smith, 2004). Thus, the use of 
duration of US in a cross-sectional data such as the NHANES, may introduce classification bias 
such that individuals with relatively shorter years of residence in the US may be considered to 
have potentially lower PFC serum concentrations, and vice versa. Future studies among 
immigrants can use multiple cross-sections or longitudinal data that will make it possible to 
follow immigrant cohorts over a period of time after their arrival in the United States. In 
addition, studies can compare the exposure characteristics of immigrants with that of populations 
in their countries of origin. This will provide more information on differences in exposure 
characteristics between immigrant subgroups. Finally, this study did not examine whether 
differences in residential segregation patterns were associated any differences in PFC-exposure 
characteristics among the native-born and foreign-born U.S. residents. Future studies can 
examine this phenomenon 
Conclusions and Recommendations  
In a representative sample of US adults, being native-born was associated with significantly 
higher serum concentrations of PFOA and PFHxS when compared to foreign-born residents. 
This association appeared to be independent of age, gender, race, age, educational level, and 
smoking status. Mean eGFR among foreign-born residents was higher than that of native-born 
residents. Among foreign-born residents, increased length of stay in the U.S. was associated with 
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increased serum concentrations of PFOS and PFHxS and decreasing eGFR. Also, increasing 
serum concentrations of PFOA, PFHxS, and PFNA were significantly associated with increased 
odds of low eGFR among foreign-born U.S. residents. The association between some PFCs and 
eGFR was significant among foreign-born individuals with longer duration of residence (10-
19years, 20+ years) but not among those who had been resident for a shorter period (<10years).  
Future studies can use trend analyses to examine the increases observed in PFC serum 
concentrations and decline in eGFR concentrations with increase in length of residence among 
the foreign-born participants.  
Differences in the mean and median concentrations of liver function indicators (ALT, GGT, 
Total bilirubin) was inconclusive among foreign-born and native-born residents. Among the 
foreign-born residents, uniform increase or decrease in serum concentrations of liver function 
indicators were not observed. Similarly, significant associations between the selected PFCs and 
liver function indicators were not conclusive. Further studies can examine this relationship. 
Increasing quartiles of a combined PFOS/PFHxS exposure variable was associated with 
increased odds of low eGFR, and elevated total bilirubin. There are currently no studies on the 
combined effect of exposure to multiple PFCs.  The findings of this study can serve as the basis 
for future more rigorous studies. 
Though the production of some PFCs has ceased in the United States, they are persistent 
environmental chemicals that are likely to have significant health and environmental effects in 
the coming years. Thus, there is the need for ongoing monitoring and research on this group of 
chemicals. Foreign-born individuals are a unique population to examine the increase in PFC 
serum concentrations over time and associated health outcomes. Also, this study has 
demonstrated that there is the need to examine the effects of simultaneous exposure to multiple 
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PFCs. Further studies can examine differences in risk for PFC-associated negative health 
outcomes between foreign-born and native-born individuals, as well as among populations with 
low levels of exposure to PFCs, with emphasis placed on PFC serum concentration increases 
over time.   
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TABLES 
Table 1: Demographic Characteristics of Study Population 
Variable N (Weighted %) 
General Sample 
(N= 5167) 
Place of Birth   
Native-born Foreign-born Length of Residence (years) Among the 
Foreign-born   
Place of Birth    <10 10 – 19 20+ 
Native-born 3678 (82.3)      
Foreign-born 1485 (17.7)   384 (33.6) 373 (26.8) 661 (39.7) 
Missing 4   67 
Sex       
Male 2521 (48.1) 1786 (47.7) 732 (49.6) 180 (48.1) 178 (49.3) 342 (51.0) 
Female 2646 (51.9) 1892 (52.3) 753 (50.4) 204 (51.9) 195 (50.7) 319 (49.0) 
Race       
Non-Hispanic White 2318 (69.2) 2202 (80.3) 116 (17.4) 28 (16.8) 27 (14.3) 60 (21.6) 
Non-Hispanic Black 1031 (10.4) 915 (11.2) 116 (6.7) 25 (5.5) 34 (7.9) 56 (7.4) 
Mexican American 801 (7.9) 300 (3.7) 500 (27.0) 115 (23.3) 125 (30.7) 223 (25.0) 
Other 1017 (12.6) 261 (4.8) 753 (48.9) 216 (54.3) 187 (47.0) 322 (45.9) 
Age (years)       
20 – 39  1729 (36.5) 1236 (35.2) 493 (42.7) 231 (66.8) 165 (50.5) 65 (15.0) 
40 – 59  1713 (39.4) 1142 (39.4) 493 (39.7) 109 (27.6) 142 (39.2) 298 (51.3) 
60+ 1725 (24.0) 1300 (25.4) 423 (17.6) 44 (5.6) 66 (10.3) 298 (33.6) 
Education Level       
< High School Diploma 1241 (17.2) 708 (14.1) 532 (32.8) 118 (29.2) 140 (36.1) 256 (31.8) 
High School Diploma 1006 (21.3) 811 (22.5) 195 (15.2) 58 (17.1) 51 (17.3) 82 (12.5) 
> High School 2385 (61.5) 1854 (63.4) 531 (52.1) 154 (53.7) 130 (46.6) 237 (55.8) 
Smoking Status       
Current Smoker 1379 (26.5) 1149 (28.8) 230 (16.0) 67 (19.0) 52 (13.1) 93 (14.5) 
Heavy alcohol use        
Yes 852 (41.4) 652 (42.3) 200 (36.4) 64 (45.1) 53 (42.3) 73 (24.6) 
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Table 2. Blood Concentrations of PFOA, PFOS, PFHxS and PFNA in Overall Sample and Stratified by Place of Birth, And Length of 
Residence    
Concentrations in ng/mL General Sample By Place of Birth Length of Residence (Years) 
  Native-born Foreign-born <10 10 – <20 20+ 
PFOA       
Mean (SE) 3.76 (0.08) 3.91 (0.09) 3.04 (0.12) 2.64 (0.24) 2.84 (0.10) 3.46 (0.13) 
Median 3.14 3.35 2.46 2.09 2.28 2.89 
Q1 0.07 – 2.01 0.07 – 2.14 0.07 – 1.60 0.10 – 1.40 0.07 – 1.49 0.07 – 2.04 
Q2 2.02 – 3.15 2.15 – 3.36 1.61 – 2.47 1.41 – 2.10 1.50 – 2.29 2.05 – 2.90 
Q3 3.16 – 4.80 3.37 – 5.00 2.48 – 3.80 2.11 – 3.20 2.30 – 3.61 2.91 – 4.40 
Q4 4.81 – 24.00 5.01 – 24.00 3.81 – 23.90 3.21 – 16.20 3.62 – 19.00 4.41 – 23.90 
PFOS       
Mean (SE) 13.41 (0.54) 13.63 (0.63) 12.42 (0.80) 8.86 (0.67) 11.82 (0.93) 16.00 (1.34) 
Median 10.01 10.29 8.19 5.60 7.90 10.59 
Q1 0.14 – 5.85 0.14 – 6.29 0.14 – 4.40 0.14 – 2.90 0.14 – 4.10 0.14 – 6.30 
Q2 5.86 – 10.10 6.30 – 10.30 4.41 – 8.20 2.91 – 6.00 4.11 – 7.91 6.31 – 10.60 
Q3 10.11 – 16.40 10.31 – 16.80 8.21 – 14.60 6.01 – 11.30 7.92 – 14.90 10.61 – 17.00 
Q4 16.41 – 281.00 16.81 – 276.00 14.61 – 281.00 11.31 – 92.10 14.91 – 83.60 17.01 – 281.00 
PFHxS       
Mean (SE) 2.41 (0.10) 2.53 (0.11) 1.81 (0.08) 1.15 (0.06) 1.59 (0.09) 2.51 (0.15) 
Median 1.60 1.70 1.19 0.80 1.11 1.79 
Q1 0.07 – 0.92 0.07 – 1.00 0.07 – 4.40 0.07 – 0.40 0.07 – 0.69 0.07 – 0.90 
Q2 0.93 – 1.60 1.01 – 1.71 4.41 – 8.20 0.41 – 0.80 0.70 – 1.12 0.91 – 1.80 
Q3 1.61 – 2.80 1.72 – 3.00 8.21 – 14.60 0.81 – 1.40 1.13 – 1.70 1.81 – 3.00 
Q4 2.81 – 81.60 3.01 – 47.80 14.61 – 81.60 1.41 – 12.80 1.71 – 14.30 3.01 – 81.60 
PFNA       
Mean (SE) 1.43 (0.06) 1.43 (0.08) 1.40 (0.06) 1.25 (0.09) 1.45 (0.09) 1.47 (0.09) 
Median 1.14 1.14 1.06 0.10 1.05 1.14 
Q1 0.05 – 0.75 0.06 – 0.79 0.06 – 0.70 0.06 – 0.57 0.08 – 0.66 0.06 – 0.75 
Q2 0.76 – 1.15 0.80 – 1.15 0.71 – 1.06 0.58 – 0.98 0.67 – 1.07 0.76 – 1.15 
Q3 1.16 – 1.64 1.16 – 1.64 1.07 – 1.72 0.99 – 1.56 1.07 – 1.80 1.16 – 1.72 
Q4 1.65 – 80.77 1.64 – 80.77 1.72 – 12.05 1.57 – 6.48 1.80 – 10.91 1.73 – 12.05 
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Table 3. Correlation Matrix of Selected PFCs 
 
   PFOA  PFOS PFHxS  PFNA 
PFOA 
   
 
 PFOS 0.70  
  
 PFHxS 0.66 0.71 
  
 PFNA 0.67 0.69  0.47 
 
 
 
Table 4. Least square geometric mean (LSGM) concentrations of PFOA, PFNA, and PFHxS by country of birth and length of 
residence 
 Least Square Geometric Mean* (95% CI) 
 PFOA PFOS PFHxS PFNA 
By Place of Birth 
Native-born 2.99 (2.83 – 3.17)* 9.90 (9.16 – 10.69) 1.57 (1.45 – 1.70)* 1.18 (1.09 – 1.28) 
Foreign-born 2.50 (2.32 – 2.70) 8.62 (7.75 – 9.58) 1.28 (1.18 – 1.38) 1.10 (1.01 – 1.21) 
By Length of Residence (Years) 
<10  2.34 (2.00 – 2.73) 7.19 (6.08 – 8.51)* 0.91 (0.80 – 1.03)* 1.04 (0.90 – 1.21) 
10 – 19   2.59 (2.30 – 2.93) 9.47 (7.99 – 11.22) 1.22 (1.07 – 1.39)* 1.23 (1.07 – 1.42) 
20+  2.88 (2.60 – 3.20) 10.04 (8.85 – 11.39)* 1.56 (1.36 – 1.78)* 1.16 (1.05 – 1.27) 
*Controlling for education level, smoking status, heavy alcohol use, impaired glucose tolerance, and hypertension diagnosis. Gender, 
age and race already accounted for in the Modification of Diet in Renal Disease study equation (Levey et al., 2006). 
*Significant at α=0.05 
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Table 5. Mean and Least Square Mean (LSM) eGFR by Place of Birth, and Length of Residence 
Variable General Sample 
Mean (95% CI) 
LSM* (95% CI) Difference in LSM 
   Estimate (95% CI) pvalue 
General Sample 89.87 (88.83 – 90.90)    
By Place of Birth 
Native-born (NB) 87.79 (86.59 – 89.00) 91.41 (83.69 – 99.14)   
Foreign-born (FB) 99.55 (97.27 – 101.83) 107.15 (91.67 – 122.62)   
NB vs. FB   -15.73 (-25.49, -5.98) 0.002* 
By Length of Residence (Years) 
<10  106.94 (103.79 – 110.09) 136.54 (126.28 – 146.80)   
10 – 19  103.74 (100.56 – 106.93) 129.22 (116.41 – 142.03)   
≥ 20 90.16 (86.63 – 93.70) 126.00 (114.98 – 137.01)   
     
<10 vs. (10-19)   7.32 (-0.08, 14.72) 0.05 
<10 vs. ≥ 20   10.55 (6.34 – 14.75) <0.001* 
 (10-19) vs. ≥ 20   3.22 (-1.95,8.39) 0.21 
*Controlling for education level, smoking status, heavy alcohol use, impaired glucose tolerance, and hypertension diagnosis. Gender, age and race 
already accounted for in the Modification of Diet in Renal Disease study equation (Levey et al., 2006) 
*Significant at α=0.05 
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Table 6.  Odds Ratios (OR) of having low eGFR for a unit increase in PFOA, PFOS, PFHxS, and PFNA Concentrations  
 OR (95% CI) 
 
PFOA PFOS PFHxS PFNA 
Model 1a 
All foreign-born 1.85 (1.46 – 2.34)* 1.49 (1.28 – 1.75)* 1.69 (1.42 – 2.00)* 1.54 (1.23 – 1.92)* 
By Length of Residence (Years) 
<10  1.55 (0.98 – 2.44) 1.16 (0.89 – 1.50) 1.30 (0.91 – 1.87) 1.30 (0.88 – 1.93) 
10 – 19  1.48 (0.86 – 2.53) 1.52 (1.02 – 2.28)* 1.36 (0.94- 1.97) 2.13 (1.24 – 3.66)* 
≥ 20 1.71 (1.21 – 2.42)* 1.34 (1.10 – 1.64)* 1.64 (1.31 – 2.06)* 1.25  (0.89 – 1.74) 
Model 2b 
All foreign-born 2.04 (1.26 – 3.28)* 1.40 (1.09 – 1.79)* 1.88 (1.48 – 2.39)* 1.44 (0.89 – 2.33) 
By Length of Residence (Years) 
<10  1.21 (0.56 – 2.63) 0.94 (0.69 – 1.28) 1.27 (0.70 – 2.31) 1.68 (0.76 – 3.71) 
10 – 19  2.96 (1.37 – 6.39)* 1.19 (0.69 – 2.04) 1.59 (0.96 – 2.64) 6.04 (2.59 – 14.11)* 
20 + 3.59 (1.45 – 8.90)* 1.11 (0.90 – 1.36) 2.38 (1.53 – 3.70)* 0.83  (0.44 – 1.60) 
aModel 1: Crude model   *Significant at α=0.05 
bModel 2: Controlling for smoking status, BMI, heavy alcohol use, impaired glucose tolerance, hypertension status, total cholesterol level, and 
education level 
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Table 7. Mean and Least Square Mean (LSM) of Alanine aminotransferase (ALT) (IU/L) by Place of Birth, and Length of Residence 
Variable General Sample 
Mean (95% CI) 
LSM* (95% CI) Difference in LSM 
   Estimate (95% CI) pvalue 
General Sample 25.74 (25.22 - 26.26)    
By Place of Birth 
Native-born (NB) 25.52 (24.89 - 26.14) 28.24 (26.13 – 30.35)   
Foreign-born (FB) 26.78 (25.78 – 27.79) 31.12 (28.45 – 33.80)   
NB vs. FB   -2.88 (-5.29 - -0.47) 0.02* 
By Length of Residence (Years) 
<10  26.80 (24.30 - 29.31) 32.93 (30.33 - 35.53)   
10 – 19  28.06 (25.54 - 30.58) 34.94 (31.20 - 38.69)   
≥ 20 25.76 (24.66 – 26.86) 32.06 (30.07 - 34.05)   
     
<10 vs. (10-19)   -2.01 (-6.40 – 2.37) 0.36 
<10 vs. ≥ 20   0.87 (-2.25 – 4.00) 0.33 
 (10-19) vs. ≥ 20   2.88 (0.07 – 5.69) 0.04* 
*Controlling for age, race/ethnicity, educational level, smoking status, heavy alcohol use, impaired glucose tolerance, and hypertension diagnosis.   
*Significant at α=0.05 
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Table 8. Mean and Least Square Mean (LSM) of Gamma glutamyl transferase (GGT) (IU/L) by Place of Birth, and Length of 
Residence 
Variable General Sample 
Mean (95% CI) 
LSM* (95% CI) Difference in LSM 
   Estimate (95% CI) pvalue 
General Sample 28.05 (26.18 – 29.91)    
By Place of Birth 
Native-born (NB) 28.33 (26.01 – 30.64) 35.30 (32.09 – 38.52)   
Foreign-born (FB) 26.70 (24.93 – 28.47) 35.66 (32.23 – 39.09)   
NB vs. FB   -0.36 (-2.94 – 2.23) 0.78 
By Length of Residence (Years) 
<10  24.56 (20.95 – 28.17) 36.48 (32.48 – 40.47)   
10 – 19  29.77 (26.63 – 32.91) 42.75 (32.48 – 40.47)   
≥ 20 26.45 (24.42 – 28.49) 37.50 (33.39 – 41.60)   
     
<10 vs. (10-19)   -6.27 (-10.99 -  -1.55) 0.01* 
<10 vs. ≥ 20   -1.02 (-4.55 – 2.52) 0.56 
 (10-19) vs. ≥ 20   5.25 (1.86 – 8.65) 0.003* 
*Controlling for age, race/ethnicity, educational level, smoking status, heavy alcohol use, impaired glucose tolerance, and hypertension diagnosis.   
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Table 9. Mean and Least Square Mean (LSM) of Total Bilirubin (mg/dL) by Place of Birth, and Length of Residence 
Variable General Sample 
Mean (95% CI) 
LSM* (95% CI) Difference in LSM 
   Estimate (95% CI) pvalue 
General Sample 0.76 (0.74 – 0.77)    
By Place of Birth 
Native-born (NB) 0.76 (0.74 – 0.78) 0.75 (0.73 – 0.77)   
Foreign-born (FB) 0.74 (0.72 – 0.76) 0.72 (0.70 – 0.74)   
NB vs. FB   0.03 (0.003 – 0.05) 0.03* 
By Length of Residence (Years) 
<10  0.75 (0.71 – 0.78) 0.73 (0.68 – 0.78)   
10 – 19  0.73 (0.70 – 0.77) 0.74 (0.69 – 0.78)   
≥ 20 0.74 (0.71 – 0.77) 0.73 (0.70 – 0.76)   
     
<10 vs. (10-19)   -0.01 (-0.06 – 0.05) 0.76 
<10 vs. ≥ 20   -0.004 (-0.05 – 0.04) 0.87 
 (10-19) vs. ≥ 20   0.005 (-0.04 – 0.05) 0.82 
*Controlling for age, race/ethnicity, educational level, smoking status, heavy alcohol use, impaired glucose tolerance, and hypertension diagnosis.   
*Significant at α=0.05 
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Table 10.  Odds Ratios (OR) of having elevated ALT for a unit increase in PFOA, PFOS, PFHxS, and PFNA Concentrations   
 OR (95% CI) 
 
PFOA PFOS PFHxS PFNA 
Model 1 a 
All foreign-born 0.93 (0.70- 1.24) 1.07 (0.82 - 1.39) 1.07 (0.85 -1.34) 0.86 (0.62 -1.18) 
By Length of Residence (Years) 
<10  1.07 (0.58 – 1.97) 1.10 (0.69 - 1.73) 1.17 (0.75 - 1.83) 0.96 (0.51 - 1.82) 
10 – 19  0.79 (0.53 - 1.18) 0.81 (0.58 - 1.13) 1.02 (0.68 – 1.53) 0.82 (0.53 - 1.28) 
≥ 20 1.00 (0.70 - 1.43) 1.07 (0.82 - 1.39) 1.19 (0.94 - 1.52) 0.80 (0.58 - 1.10) 
Model 2 b 
All foreign-born 1.03 (0.70 -1.50) 1.05 (0.77 – 1.45) 1.21 (0.88 – 1.65) 0.87 (0.58 -1.30) 
By Length of Residence (Years) 
<10  1.14 (0.49- 2.67) 1.11 (0.59 – 2.10) 1.14 (0.66 - 1.98) 0.87 (0.38 - 1.95) 
10 – 19  0.80 (0.49 - 1.31) 0.82 (0.55 - 1.20) 0.99 (0.63 - 1.56) 0.83 (0.50 - 1.40) 
20 + 1.49 (1.00 - 2.22)* 1.37 (1.02 - 1.82)* 1.65 (1.28 - 2.14)* 1.01 (0.67 - 1.52) 
aModel 1: Crude model   *Significant at α=0.05 
bModel 2: Controlling for race, age, smoking status, BMI, heavy alcohol use, impaired glucose tolerance, hypertension status, total cholesterol level, 
and education level 
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Table 11.  Odds Ratios (OR) of having elevated GGT for a unit increase in PFOA, PFOS, PFHxS, and PFNA Concentrations   
 OR (95% CI) 
 
PFOA PFOS PFHxS PFNA 
Model 1a 
All foreign-born 1.46 (1.09 - 1.95)* 1.31 (1.05 - 1.65)* 1.22 (0.99 - 1.51) 1.40 (1.01 - 1.92)* 
By Length of Residence (Years) 
<10  1.24 (0.73 - 2.11) 1.15 (0.85 - 1.54) 1.24 (0.84 - 1.84) 0.98 (0.64 -1.49) 
10 – 19  1.17 (0.69 - 2.00) 1.24 (0.80 - 1.91) 1.00 (0.63 - 1.59) 1.35 (0.73 -2.48) 
≥ 20 1.91 (1.04 – 3.51)* 1.36 (0.94 - 1.97) 1.27 (0.93 - 1.74) 1.57 (0.85 - 2.90) 
Model 2b 
All foreign-born 1.24 (0.87 - 1.76) 1.24 (0.95 - 1.62) 1.10 (0.87 - 1.41) 1.24 (0.84 - 1.83) 
By Length of Residence (Years) 
<10  0.96 (0.53 - 1.78) 0.97 (0.71 - 1.33) 1.06 (0.65 - 1.74) 0.74 (0.49 - 1.10) 
10 – 19  0.84 (0.49 - 1.42) 1.03 (0.65 - 1.63) 0.81 (0.48 - 1.37) 1.02 (0.55 -1.88) 
20 + 1.98 (1.07 - 3.69)* 1.37 (0.93 -2.03) 1.35 (0.98 - 1.87) 1.44 (0.78 - 2.68) 
aModel 1: Crude model   *Significant at α=0.05 
bModel 2: Controlling for race, age, smoking status, BMI, heavy alcohol use, impaired glucose tolerance, hypertension status, total cholesterol level, 
and education level 
  
PFCS AND RENAL AND LIVER FUNCTION AMONG FOREIGN-BORN 
78 
 
Table 12.  Odds Ratios (OR) of having elevated Total Bilirubin for a unit increase in PFOA, PFOS, PFHxS, and PFNA Concentrations  
 OR (95% CI) 
 
PFOA PFOS PFHxS PFNA 
Model 1a 
All foreign-born 1.39 (0.83 - 2.32) 1.43 (0.98 -2.09) 1.43 (1.03 -1.97)* 1.57 (0.85 - 2.91) 
By Length of Residence (Years) 
<10  1.02 (0.33 - 3.15) 1.25 (0.57 - 2.75) 1.25 (0.63 - 2.47) 1.06 (0.39 - 2.91) 
10 – 19  1.57 (0.88 -2.80) 1.79 (1.11 - 2.89) 1.66 (1.04 - 2.66) 2.13 (1.44 - 3.17)* 
≥ 20 1.82 (0.93 - 3.54) 1.33 (0.81 - 2.20) 1.44 (1.00 - 2.07) 1.97 (0.67 - 5.81) 
Model 2b 
All foreign-born 1.63 (0.94 - 2.83) 1.69 (1.12 -2.53)* 1.60 (1.11 -2.30)* 1.81 (1.05 -3.13)* 
By Length of Residence (Years) 
<10  0.96 (0.29 - 3.20) 1.26 (0.55 - 2.90) 1.29 (0.62 - 2.66) 0.99 (0.38 - 2.57) 
10 – 19  1.70 (0.86 - 3.40) 2.31 (1.13 - 4.72)* 2.01 (1.08 - 3.72)* 3.02 (1.20 - 7.65)* 
20 + 2.11 (0.96 - 4.64) 1.34 (0.76 -2.37) 1.50 (0.86 - 2.63) 1.59 (0.79 - 3.19) 
aModel 1: Crude model   *Significant at α=0.05 
bModel 2: Controlling for race, age, smoking status, BMI, heavy alcohol use, impaired glucose tolerance, hypertension status, total cholesterol level, 
and education level 
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Table 13:  Assessment of the factor loading matrix of PFC serum concentration principal components   
 
Variables PFOS/ PFHxS PFOS/ PFNA PFOA 
PFOA 0.38 0.38 0.83* 
PFOS 0.68* 0.64* 0.20 
PFHxS 0.90* 0.16 0.34 
PFNA 0.18 0.90* 0.33 
* Items with factor loadings 0.4 or greater are retained for that component 
 
 
Table 14: Crude and Adjusted Logistic Regression of PFC Serum concentration principal components and risk of low eGFR  
 
OR (95% CI) 
 PFOS/ PFHxS PFOS/ PFNA PFOA 
Model 1 a 
Quartile    
1 Ref. Ref. Ref. 
2 1.64 (1.40 -1.91) * 1.03 (0.88 - 1.21) 1.27 (1.09 - 1.49) 
3 1.85 (1.58 - 2.16) * 1.12 (0.96 - 1.32) 1.25 (1.06 - 1.46) 
4 2.89 (2.46 - 3.40) * 1.33 (1.13 - 1.55) 1.27 (1.08 - 1.49) 
Model 2 b 
Quartile    
1 Ref. Ref. Ref. 
2 1.38 (1.04 - 1.83)* 0.91 (0.68 - 1.20) 1.24 (0.90 - 1.71) 
3 1.53 (1.16 - 2.01)* 0.91 (0.69 - 1.20) 0.96 (0.71 - 1.30) 
4 2.41 (1.82 - 3.19)* 1.14 (0.86 - 1.50) 1.22 (0.90 - 1.65) 
a Mutually adjusted for all other principal components factors *Significant at α=0.05 
b Adjusted for all principal components factors, smoking status, BMI, heavy alcohol use, impaired glucose tolerance, hypertension status, total 
cholesterol level, and education level 
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Table 15: Crude and Adjusted Logistic Regression of PFC Serum concentration principal components and risk of elevated ALT  
 
OR (95% CI) 
 PFOS/ PFHxS  PFOS/ PFNA  PFOA 
Model 1 a 
Quartile    
1 Ref. Ref. Ref. 
2 1.12 (0.88 - 1.44) 1.02 (0.80 - 1.32) 0.78 (0.59 - 1.02) 
3 1.02 (0.80 - 1.31) 0.81 (0.63 - 1.06) 1.10 (0.85 - 1.42) 
4 0.75 (0.58 - 0.98) 0.92 (0.71 - 1.19) 1.28 (1.00 - 1.64)* 
Model 2 b 
1 Ref. Ref. Ref. 
2 1.36 (0.85 - 2.18) 0.91 (0.57 - 1.46) 0.54 (0.32 - 0.93) 
3 1.55 (0.96 - 2.50) 0.94 (0.59 - 1.50) 0.69 (0.43 - 1.12) 
4 1.34 (0.82 - 2.18) 1.36 (0.86 - 2.16) 0.88 (0.56 - 1.42) 
a Mutually adjusted for all other principal components factors *Significant at α=0.05 
b Adjusted for all principal components factors, race, age, smoking status, BMI, heavy alcohol use, impaired glucose tolerance, hypertension 
status, total cholesterol level, and education level 
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Table 16: Crude and Adjusted Logistic Regression of  PFC Serum concentration principal components and risk of elevated GGT 
  
OR (95% CI) 
 PFOS/ PFHxS PFOS/ PFNA PFOA 
Model 1 a 
Quartile    
1 Ref. Ref. Ref. 
2 1.13 (0.89 - 1.43) 0.87 (0.68 - 1.13) 1.26 (0.98 - 1.61) 
3 1.00 (0.78 - 1.27) 1.06 (0.83 - 1.36) 1.27 (0.99 - 1.63) 
4 0.83 (0.64 - 1.07) 1.20 (0.95 - 1.53) 1.22 (0.95 - 1.57) 
Model 2 b 
Quartile    
1 Ref. Ref. Ref. 
2 0.99 (0.65 - 1.52) 0.72 (0.47 - 1.12) 1.23 (0.77 - 1.98) 
3 1.09 (0.72 - 1.67) 0.93 (0.62 - 1.42) 1.01 (0.64 - 1.60) 
4 0.76 (0.49 - 1.18) 0.93 (0.61 - 1.41) 1.25 (0.80 - 1.95) 
a Mutually adjusted for all other principal components factors *Significant at α=0.05 
b Adjusted for all principal components factors, race, age, smoking status, BMI, heavy alcohol use, impaired glucose tolerance, hypertension 
status, total cholesterol level, and education level 
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Table 17: Crude and Adjusted Logistic Regression of PFC Serum concentration principal components and risk of elevated Total 
Bilirubin 
 
 
OR (95% CI) 
 PFOS/ PFHxS PFOS/ PFNA PFOA 
Model 1 a 
Quartile    
1 Ref Ref Ref 
2 1.35 (0.91 – 2.00) 0.85 (0.59 - 1.22) 1.22 (0.83 - 1.80) 
3 1.56 (1.06 - 2.29) * 0.98 (0.69 - 1.40) 1.38 (0.95 - 2.01) 
4 1.99 (1.37 - 2.88) * 1.19 (0.84 - 1.68) 1.80 (1.25 - 2.58) * 
Model 2 b 
Quartile    
1 Ref Ref Ref 
2 2.33 (1.17 - 4.64) * 0.99 (0.56 - 1.75) 1.00 (0.50 - 2.00) 
3 2.47 (1.24 - 4.92) * 1.20 (0.69 - 2.08) 1.20 (0.63 - 2.29) 
4 2.82 (1.42 - 5.61) * 1.18 (0.66 - 2.10) 1.44 (0.76 - 2.72) 
a Mutually adjusted for all other principal components factors *Significant at α=0.05 
b Adjusted for all principal components factors, smoking status, BMI, heavy alcohol use, impaired glucose tolerance, hypertension status, total 
cholesterol level, and education level 
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APPENDICES 
Appendix 1. International Guideline Health-based Values for PFOA and PFOS * 
Country/Agency  Guideline Value 
(μg/ L) 
Source  
PFOA PFOS 
German Ministry of Health  0.3  0.3 German Ministry of Health (2006)  
United Kingdom (UK) Drinking 
Water Inspectorate  
5.0  1.0 UK Drinking Water Inspectorate 
(2009)  
Danish Ministry of the 
Environment  
0.3  0.1 Danish Ministry of the Environment 
(2015)  
Dutch National Institute for 
Public Health and the 
Environment 
- 0.09 RIVM (2010) 
Swedish National Food Agency  0.09 Livsmedelsverket (2014), cited in 
Danish Ministry of the Environment 
(2015) 
* Cited in (USEPA, 2016a, 2016b) 
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Appendix 1: Molecular Structures of PFOA, PFOS, PFHxS, and PFNA 
 
Figure 1:  Molecular structure of Perfluorooctanoic acid (PFOA)
 
 
 
 
Figure 2:  Molecular structure of perfluorooctane sulfonic acid (PFOS)
 
 
 
 
Figure 3:  Molecular structure of perfluorohexane sulfonic acid (PFHxS) 
 
 
 
 
Figure 4:  Molecular structure of perfluorononoic acid (PFNA)
 
 
